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Abstract 
Prostaglandins are group of prostanoids that exerts different biological actions 
towards different part of the body. From years of studies, prostaglandins were 
known for their action in contractile and relaxant effects on smooth muscle. 
Among the different actions in different organs, prostaglandins also exhibit a 
regulatory effect in cell proliferation and differentiation. Much work is now 
focusing on the role of prostaglandins towards cell differentiation. It is now 
believed that inducer-mediated cell differentiation involves the production and 
regulation of prostaglandins. 
Prostaglandin Ej (PGE?) is one of the major prostaglandin that can induce cell 
differentiation, especially for the haemopoietic cells in the marrow 
microenvironment. We found that when 25 \iM of PGE? was used to induce the 
murine myelomonocytic leukemia JCS cell, 74 % of the cell was induced to 
differentiate into macrophage. When the same concentration of PGE? was cultured 
with bone marrow cells, it had led to 71 % of granulocytic colony formation. The 
different response of JCS and bone marrow cells towards PGE� induction may be 
due to the differential expression of PGE receptors. For the expression of EPS 
subtype, bone marrow cells express the EP3a, |3 and y receptors whereas only EP3丫 
isoform was found in JCS cells. 
Since JCS cells can be induced to differentiate into cells of both monocytic and 
granulocytic lineage, the study of gene expression profile of JCS cell under PGE� 
induction may give some clues in understanding the lineage preference in progenitor 
cell differentiation. It also tells the underlying mechanism of PGE: induced cell 
differentiation. In order to get more information, microarray was used and 588 
mouse genes were screened for their expression after 5 hours of 25 i^M PGE? 
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treatment. 
After hybridization, 6 genes were shown to be upregulated for more than two-
fold. There were 11 genes with detectable hybridization signals in PGE2 induced 
cells but none in the uninduced cells. They were considered to be induced genes. 
On the other hand, a total of 56 genes were down regulated for more than two-fold. 
Three genes were with detectable hybridization signals in uninduced cells but none 
in the PGE2 induced cells, and they were considered as repressed genes after the 
induction. The regulated genes were mainly oncogenes, tumor suppressors and cell 
cycle regulators. Others related to stress response, apoptosis, DNA synthesis, 
repair and recombination were also included. Some of them are transcription 
factors, receptors for growth factor, cytokines and also hormones. 
PGE2 may be used, together with other anti-leukemia therapies, to inhibit the 
growth of leukemia cells. Further studies are needed to reveal the exact role of 
PGE2 in inducing myeloid leukemia cell differentiation. It is hope that the 
mechanism of cell differentiation can be understood and more potent anti-leukemia 
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Chapter One General introduction 
1.1 Haemopoiesis 
1.1.1 Background 
Within the blood, there exist different kinds of cells that are having unique 
functions and characteristics. Some of them may help to transport oxygen whereas 
some may be involved in the inflammatory response and the production of 
antibodies. Some may function entirely within the vascular system and some may 
perform their function elsewhere. The common features they shared are that they 
all have short lifespan and are produced throughout the life of the animal. The 
process of blood cells formation is called haemopoiesis. 
The first haemopoietic cells arise from the Blood Island of the yolk sac. 
During the first trimester, haemopoietic activity is dominated by erythropoiesis and 
large nucleated red blood cells are produced. After migrated from the yolk sac to 
the fetal liver and spleen, haemopoietic cells produce mainly macrocytic red blood 
cells in the second trimester. Sooner, the central and peripheral skeletons take over 
the haemopoietic production. In adult, more than 95 % haemopoietic tissues are 
located in bone marrow in scattered locations throughout the body (Metcalf and 
Nicola, 1995). 
According to the stem cell theory, all the eight major haemopoietic lineages are 
derived from the haemopoietic stem cells. For each lineage, three sequential cell 
populations can be identified. They are the stem cells, the progenitor cells and the 
dividing and maturing populations (Metcalf and Nicola, 1995). The stem cells are 
self-sustaining and are responsible for the production of committed progenitor cells. 
Mostly, the stem cells are having large nuclear which often have prominent nucleoli. 
Cytoplasm of the cell is agranular and not basophilic and they represent the least 
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population (1 per 10^ marrow cells) within the blood components. 
The progenitor cells comprise up to 1 % of haemopoietic cells and they show 
minimal capacity for self-regeneration. Usually they are being committed to a 
specific cell lineage. Progenitor cells are mono-nucleated cells with the nuclei 
sized from medium to large and they are having agranular basophilic cytoplasm. 
The dividing and maturing populations are those progeny of the progenitor cells in a 
particular cell lineage. The higher the maturity of the cells，the lower the capacity 
of cells undergoes further proliferation. 
1.1.2 Regulation 
Haemopoiesis is such a complicated process that precise coordination should be 
made in order to maintain proper blood cell levels. It is thought that both positive 
and negative feedback systems are involved in the regulation. Those elements that 
keep a close contact with the blood cells can act as the inductor and regulate the 
normal blood cell levels. Among them, the stromal cells and the haemopoietic 
regulators can be considered as the most crucial ones. 
1.1.2.1 Stromal cells 
Stromal cells are groups of cells including fibroblasts, endothelial cells, 
osteoblasts and adipocytes that line the endosteal surface in the bone marrow cavity. 
They provide physical support and excellent microenvironment for orderly cell 
differentiation. There was evidence showing that proliferation inhibition occurred 
when a long-term culture initiating cells (LTC-IC) were cultured in contact with 
glutaraldehyde-fixed stroma (Verfaillie and Catanzaro，1996). It indicates that 
stromal cells can regulate haemopoiesis by adhesive interaction with the blood cells. 
On the contrary, the secretion of various regulatory molecules is also important. 
Some of the factors are soluble and some may be membrane-bound molecules. 
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These include the adhesion molecules, glycoprotein hormones and proteoglycan 
matrix. 
1.1.2.2 Haemopoietic regulator 
Haemopoietic regulator is a term to describe those elements that regulate 
haemopoietic cell proliferation and differentiation. These include the regulatory 
molecules secreted by the stromal cells. The regulators are typically glycoproteins 
that can be produced by different cell types throughout the body. Examples of 
some haemopoietic regulators are listed at table 1.1. 
The first haemopoietic regulator being discovered is erythroprotein. It 
regulates the maturation of erythrocytes. Later, the colony stimulating factors were 
being found and those are the elements that stimulate colony formation of different 
cell lineages. Colony stimulating factors can be detected in all mouse tissues 
extract (Sheridan, 1971) and they are the products of bone marrow stromal cells, T-
lymphocytes and monocytes. 
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Table 1.1 Haemopoietic growth factors grouped according to their known target 
cells (adopted from Metcalf and Nicola, 1995) 
Target population Haemopoietic growth factors 
Stem cells SCF，IL-1，IL-6，IL-3 (Multi-CSF), GM-
CSF, G-CSF, M-CSF，LIF, IL-12，flk-
ligand 
Granulocytes G-CSF, GM-CSF, IL-3, IL-6, SCF, IL-11 
Monocyte-macrophages M-CSF, GM-CSF, IL-3, 0-CSF 
Eosinophils IL-3, GM-CSF, IL-5 
Megakaryocytes SCF, IL-3, GM-CSF, IL-6, ILF，mpl-
ligand 
Mast cells IL-3, SCF 
Erythroid cells Early: SCF, IL-3, GM-CSF; Late: Epo 
T-Lymphocytes IL-1, IL-2, IL-4, IL-10，IL-7 
B-Lymphocytes SCF, IL-7, IL-4, IL-6, IL-2 
Dendritic cells GM-CSF 
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Cytokines like the interleukins are also a group of haemopoietic regulators that 
regulate haemopoiesis. Up till now, there are more than 60 cytokines being studied 
(Ronald and Lance, 1998). Cytokines can be divided into several groups, including 
the haemopoietins, the interferons, tumor necrosis factor (TNF)- related molecules， 
immunoglobulin superfamily members and chemokines. This classification may 
relate to the receptor homology (Paul and Seder, 1994). 
The quantitative importance of a particular regulator in controlling cell 
production in a lineage can vary according to the particular stage the cells are in the 
lineage. It also depends on the presence or absence of other regulators that interact 
with the regulator (Metcalf, 1993). In other words, the regulators may function in a 
pleiotropy and redundant manner (Kishimoto et al., 1994). The similar effect of 
leukemia inhibitory factor (LIF) and interleukin-6 (IL-6) to induce monocytic 
differentiation of murine leukemia cell line (Ml) is a good example to illustrate this 
point (Kishimoto et al., 1994) 
1.1.2.3 Haemopoietic regulator receptors and signal transduction 
Haemopoietic regulators give their action by binding to their cognate cell-
surface receptors of the haemopoietic cell. Most regulator receptors consist of 
multiple chain namely private ligand-binding receptors specific for each regulator 
and public signal transducers common to several regulators. Homo- or hetero-
dimerization of receptor molecules by ligand binding triggers the association and 
activation of intracellular tyrosine kinases. This activates the specific transcription 
factors in the cytoplasm and signals are transported to the nucleus through these 
small molecules. Expression of a particular gene will then turn on which the 
product can trigger cell proliferation and differentiation program (Kishimoto et al” 
1994). 
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Small portions of regulator receptors are transmembrane proteins having a 
protein tyrosine kinase (PTK) domain. The amino-terminal ligand-binding 
domains are located at the extracellular side of the plasma membrane. They are 
responsible for the binding of the haemopoietic regulators. Once the haemopoietic 
regulator binds to the receptor, tyrosine phosphorylation will then possess at the 
tyrosine residues of the C-terminal tail. The phosphorylation process then 
initiates sequential biochemical responses and switches on the signal transduction 
pathways. 
Most often, SRC homology 2 (SH2) domain-containing proteins are involved 
in the signaling by mediating protein-protein interactions through the tightly binding 
with the phosphorylated tyrosine residues. Such binding of the signaling protein to 
the receptor will lead to the activation of specific transcription factor that then binds 
to specific enhancer sequence of a structural gene. Transcription factors are 
usually dimers of identical or different protein subunits. For those involved in the 
haemopoiesis, they are grouped into families on the basis of the protein domains 
used in dimerisation and DNA binding. Some of the major groups of the 
transcription factors are listed in Table 1.2. 
Quite a large number of regulator receptors do not contain a PTK domain. 
Nevertheless, they interact with the transcription factors via the cytoplasmic PTKs 
of the Janus kinase (Jak) family (Ihle, 1995). Jak family includes members of Jakl, 
Jak2 and Tyk2. Cytokines including ciliary neurotrophic factor (CNTF), leukemia 
inhibitory factor (LIF), oncostatin M (OSM) and interleukin-6 (IL-6) utilize the Jak 
family to transduce their signals. The p-receptor components of the cytokines 
associate with the Jak family and induce distinct patterns of Jak-Tyk kinases 
phosphorylation in different cell lines. Jakl and Tyk2 are required for interferon 
a (IFN-a) singaling, Jakl and Jak2 are required for IFN-y signaling, while EPO, 
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growth hormone (GH) and IL-3 activate only Jak2 (Stahl et al” 1994). 
After activated by the IFN-receptor, the Jak family then phosphorylates 
substrate proteins called STATs (Signal transducers and activators of transcription) 
(Darnell Jr et al., 1994). STAT proteins are located in the cytoplasm and 6 types of 
STATs were found. IL-2, 3，7 are some of the cytokines that activate STATs 
presumably as a direct result of Jak PTK activation (Taniguchi, 1994). 
Abnormalities in the Jak/STAT signaling pathway can account for autosomal severe 
combined immunodeficiency (SCID) (Macchi et al,, 1995). 
Src-family PTK is another non-receptor tyrosine kinase family, with family 
members src, yes, fyn, lyn, Ick, blk, hck, fgr and yrk. This family leads to the 
activation of the nuclear proto-oncogenes c-juns and c-fos (Taniguchi and Minami, 
1993). Syk-ZAP-70, Btk-Tec family and the Fes family are also closely involved 
in the signal transduction of haemopoietic regulators (Taniguchi, 1995). Activation 
of family of serine/threonine kinases known as the extracellular-signal regulated 
kinases (erk) or mitogen-activated protein (MAP) kinases is also believed to be 
critical part of one of the signal transduction pathways controlling mitogenesis and 
cell division (Welham et al” 1994). 
7 
Table 1.2 Transcription factor families involved in haemopoiesis and 
leukemogenesis (adopted from Provan and Gribben, 2000) 
Family name Characteristics Examples 
Leucine-zipper Regularly repeated leucine FOS, JUN 
residues mediate dimerisation 
Helix-loop-helix (HLH) Helix-loop-helix dimerisation MYC, MAX, E2A, 
motif TAL-l(SCL)，TEL, 
(ETV6) 
Homeobox Dimerisation domain PBX-1, HOX11 
homologous to Drosophila 
homeobox transcription factors 
Zinc finger DNA-binding 'fingers' PML, retinoic acid 
generated by chelation of Zn]. receptor a, ETO，MLLl 
by four cysteine residues (ALLl) 
LIM Metal-binding domains similar Rhombotin 1 and 2 
to zinc fingers 
R E L Homology to retroviral v-REL. N F K B , BCL-3 
Activated consequent to 
dissociation from inhibitory 
subunits 
STAT Dimerisation mediated by STATs 1 to 6 
binding of SH2 domains to 
phosphotyrosine residues 
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1.2 Disorder of haemopoiesis 
1.2.1 Causes 
Chromosomal translocation, gene mutation and inversion may all generate 
abnormal signaling molecules, which strongly interrupt the signaling pathways. 
The first human cancer that was identified to be associated with a consistent 
chromosomal abnormality was chronic myeloid leukemia (CML). It is 
characterized cytogenetically by a t(9;22)(q34;qll) reciprocal translocation which 
gave origin to a hybrid bcr-abl gene, encoding a fusion protein with 
elevated tyrosine kinase activity and transforming abilities (Melo, 1996, Fernandes 
et al., 1996). Overexpression of certain regulatory proteins will make the process 
out of control and leads to leukemia, the malignant transformation of blood cells. 
Gene disorder may be caused by different means. Radiation, for example, is a 
weak but significant leukemogen. Some chemotherapeatic agents such as 
alkylating agents and topoisomerase II inhibitors are leukemogenic, as are solvents 
such as benzene (Shin and Bellenir，1999). Previous haemologic disorders such as 
polycythemia vera, myeloid metaplasia, paroxysmal nocturnal hemoglobinuria and 
myelodysplasia can also lead to leukemia, like acute lymphocytic leukemia (ALL) 
(Schiffman, 1998). 
1.2.2 Types of leukemia 
Leukemia is grouped by the developmental speed of the disease (acute or 
chronic) and the types of blood cell involved. In acute leukemia, abnormal blood 
cells are usually blast cells that can neither carry out their normal functions nor 
undergo terminal differentiation. The disease is usually fatal because of 
neutropenia, resulting in infection, and thrombocytopenia, leading to hemorrhage. 
In chronic leukemia, blast cells are also present and they may carry out part of their 
normal functions. The number of blast cells increases gradually and the cells are 
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kept differentiating to become mature cells. 
Leukemia may arise from either lymphoid or myeloid cells. The followings 
are the most common types of leukemia: 
參 Acute lymphocytic leukemia (ALL) 
• Acute myeloid leukemia (AML) 
• Chronic lymphocytic leukemia (CLL) 
參 Chronic myeloid leukemia (CML) 
• Hairy cell leukemia 
1.2.3 IVeatment of leukemia 
Chemotherapy, radiotherapy, bone marrow transplantation and biological 
therapy are the most common ways in curing leukemia. Among them, 
chemotherapy will be discussed below and a new method, the cytodifferentiation 
therapy, will also be introduced. 
Chemotherapy 
Cytotoxic therapy has long been used and has significantly extended the 
survival of cancer patients. Alkylating agents, such as mechlorethamine and 
cyclophosphamide, are used in treatment of primary malignancy. Subgroup of the 
alkylating agents, the nitrosures, including carmustine (BCNU), lomustine (CCNU) 
and sesmustine (methyl-CCNC) are also applied to patients with primary cancer. 
Unfortunately, it is also found to have a positive correlation between survival and 
the risk of therapy-related acute nonlymphocytic leukemia (t-ANLL), or say，the 
secondary malignancy. Many alkylating agents were proved to be leukemogenic, 
and a positive correlation between the cumulative dose of alkylating agents and the 
risk for development of leukemia was observed (Pape, 1988). Similar side effect, 
namely an increased in tumor burden, was also observed in patients treated with 
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busulfan (Hehlmann, 1996). 
Cytodifferentiation therapy 
Under the environmental influences, cancer cells are found to differentiate into 
either cells with the abnormalities of normal cells, and this became the foundation of 
cytodifferentiation therapy. The CSFs，having the ability to enhance white cell 
levels without obvious toxic effect, are suitable for cytodifferetiation therapy of 
leukemia. The first clinical trial using recombinant GM-CSF was carried out in 
1987 (Groopman et al., 1987) and since then, G-CSF，M-CSF and IL-3 were being 
tested for their potential use (Metcalf and Nicola, 1995). But as CSFs and other 
cytokines regulate different cell lineages through a complicated network, different 
leukemic cell clones may show different sensitivity and response to the 
haemopoietic regulators. This urges the isolation and identification of new potent 
anti-leukemia drugs. 
Retinoids including retinoic acid (RA) are analogs of vitamin A. These 
compounds were shown to inhibit cell growth and to promote cell differentiation in 
some tumor cell lines. Differentiation of the human myelogenous leukemia cell 
line HL-60 by RA had led to the finding that cells from patients with acute 
promyelocytic leukemia (APL) were able to undergo terminal differentiation after 
RA treatment (Breitman et al” 1994). All-trans-retinoic acid (ATRA), when tested 
in APL, had been shown to induce complete remission in 64 % to 96 % of patients 
and with rapid resolution of the coagulopathy, which is a major cause of early 
morbidity and mortality (Tallman, 1994). Combinations of RA with cyclic 
adenosine monophosphate (cAMP)-elevating agents were found to synergistically 
induce differentiation of HL-60 cells (Breitman et al., 1994). 
Though clinical trials of ATRA seem to be satisfactory, there are still many 
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drawbacks. Dryness of the skin and membrane, cheilosis, headache, 
hypertriglyceridemia, bone pain and pseudotumor cerebri may appear in patients 
receiving ATRA therapy (Tallman, 1994). 
Finding of more suitable anti-leukemia drugs with anti-proliferative and 
differentiation-inducing activity toward different leukemia cells is still the long-term 
goal of the research. Besides, the precise mechanism by which the drugs exert 




Prostaglandins are groups of prostanoids that exert different biological actions 
in different parts of the body. From years of studies, prostaglandins are known for 
their actions in contractile and relaxant effects on smooth muscle. Within the 
vascular tissue, the gastrointestinal smooth muscle, respiratory tract, reproductive 
organs, urinary system and eye muscle, one can easily detect more than one kinds of 
prostaglandins and their corresponding receptors. 
Prostaglandins have been shown to affect the sensory and motor neurons, 
exhibiting both inhibitory and excitatory actions. The generation of protaglandins 
is also noted in platelet aggregation in response to a variety of natural stimuli 
(Coleman et al., 1989). In kidney, prostaglandins of the E，I and F series are 
produced with a marked regional variation. They may be involved in counter 
acting the vasoconstriction of afferent and efferent arteries, and modulating the 
cortical events like renal blood flow, renin release and glomerular filtration rate. In 
gastric mucosa, prostaglandins regulate the secretion of gastric acid and sodium 
chloride (NaCl)-rich juice, whereas in intestine, prostaglandins can both stimulate 
secretion and inhibit absorption (Coleman et al., 1989). 
The pathophysiological actions of prostaglandins are also numerous. In 
inflammatory conditions, no matter they are induced by antigen-antibody reactions, 
immune/autoimmune response or mechanical trauma， large amount of 
prostaglandins is produced. Some of the prostaglandins like PGE? are potent 
vasodilators and can inhibit the function and proliferation of T cell. Moreover, it is 
also a hyperalgesic agent and has well-documented resorptive actions on both 
cartilage and bone. Pyrogen induced fever is also mediated by prostaglandins. 
Nonsteroidal antiinflammatory drugs such as aspirin and indomethacin, which are 
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inhibitors for prostaglandins production, are effective in mediating antipyretic 
activities. Besides, prostaglandins have also been reported to cause the impairment 
of lung function in asthma patients. The effect may be due to the induction of non-
specific hypersensitivity reaction (Coleman et al., 1989). 
In addition, prostaglandins also exhibit a regulatory effect on cell proliferation 
and differentiation, and that is the area we are most interested in. Being released in 
large quantities by different tumour cells, prostaglandins may play a role in tumour 
progression. Before going into details，it is advisable to know more about 
prostaglandins. 
1.3.2 Types and biosynthesis 
Prostaglandins are oxygenated derivatives of the C20 fatty acid that is mainly 
arachidonic acid. Arachidonic acid is a major constituent of membrane 
phospholipids. By the action of phospholipase A?, fatty acyl chains of 
phospholipids is esterified at the 2-acyl position and free arachidonic acid is being 
released. Prostanoids including prostaglandins (PGs) and thromboxanes (TXs) are 
then formed from metabolized arachidonic acid. 
The first prostaglandin formed from arachidonic acid is PGG? PGG2 is 
converted to PGH: through the action of prostaglandin G/H synthase. 
Prostaglandin G/H synthase is a dimer composed of identical subunits exhibits 2 
distinct catalytic activities: a bis-oxygenase (cyclo-oxygenase) involves in PGG2 
formation and hydroperoxidase to yield PGH2 (Smith, 1989, Shimizu and Wolfe, 
1990). PGG2 and PGH� are unstable and quickly decompose to mixtures of PGD, 
PGE，PGF, 12-L-hydroxy-5,8,10-heptadecatrienoic acid and malondialdehyde. 
Excess prostaglandins cannot be stored and they are produced when cell is in 
response to cell-specific proteolytic or hormonal stimuli. 
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Up till now，there are more than 10 types of prostaglandins being found and 
they are named from Prostaglandin A to J. Further classification is made according 
to the number of double bonds in their side chains. The 1-series compounds have a 
trans-13 double bond and are formed from "/-homolinolenic acid (8，11，14-
icosatrienoic acid). The 2-series having cis-5 and trans-13 double bonds are 
formed from arachidonic acid (5，8,ll,14-icosatetraenoic acid) whereas the 3-series 
having an addition of cis-17 double bonds are formed from EPA (timodonic acid, 
5,8,11,14,17-icosapentaenoic acid) (Coleman et al” 1989). 
1.3.3 Prostaglandin receptors 
Prostaglandins can act in both autocrine and paracine fashion, with functions 
similar to local hormones in response to biosynthetic stimulus. They can trigger 
different signaling pathways once bind to their corresponding receptors. 
Prostaglandin receptors belong to a new subfamily of the rhodopsin type 
receptor. They have been classified as DP, EP, FP, IP and TP types (Jones et al., 
1997). The receptors are primarily or exclusively located in the plasma membranes. 
They can be found not only at the outer membranes, but also the membranes of 
intracellular organelles such as nuclei, lysosomes, rough endoplasmic reticulum and 
the Golgi elements (Rao, 1988). 
Prostaglandin E receptors can be one example to illustrate the complexity of 
prostaglandin receptors. For PGE, there are four groups of receptors, the EPl, 2, 3 
and 4 receptors that consist of 405, 362，365，513 amino acids respectively. 
Hydrophilicity analysis had shown that the receptors contain seven hydrophobic 
segments corresponding to the seven membrane spanning regions (Nammya, 1997). 
The conserved arginine in the seven transmembrane domains may act as an 
attachment site for the a-carboxyl group of the prostaglandin molecules and it was 
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shown that the four receptors were derived from different genes. 
PGE2-activated EPl lead to an increase in intracellular Ca^ ^ concentration and 
evoked weak PI response (Nammiya，1997), which may link to phospholipase C 
(Simonson et al” 1997). This action mediates contraction of non-vascular smooth 
muscle (Jones et al” 1997). EP2 increased the level of cAMP and evoked no PI 
response while EPS decreased forskolin-elevated level of intracellular cAMP. For 
EPS, it may couple to Gi to inhibit adenylate cyclase (Narumiya，1997). As EP2 
and 3 have opposite effect, they respond differently upon ligand attachment. EP2 
receptor mediates smooth muscle relaxation and EP3-receptors mediate a variety of 
effects, including smooth muscle contraction, inhibition of transmitter release, 
inhibition of gastric acid secretion and potentiation of platelet aggregation (Jones 
et al., 1997). 
Alternative splicing of EP mRNA is responsible for the generation of different 
molecular isoforms. For EPS receptors, at least 4 isoforms were found. The 4 
isoforms，with almost identical ligand binding specificity, are all identical from the 
N-terminus to the ten-amino acids in the carboxyl tail. The protein sequences 
differ only at the end portion of the C-terminal. EP3A couples to Gi to induce 
inhibition of adenylate cyclase, EP3B and C couple to Gs to increase cAMP, EP3D 
couples to Gp, in addition to Gi and Gs, to evoke pertussis toxin-insensitive PI 
response (Narumiya, 1997). 
Prostanoid receptors are grouped according to their functions. The PGI 
receptor, the EP2 receptor and the PGD receptor have all been classified as relaxant 
prostanoid receptors, and their primary structures are closely related. The TXA2 
receptor, the EPl receptor and the PGF receptors all preferentially raise intracellular 
calcium and can be functionally classified as contractile prostanoid receptors (Hirata 
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et al” 1994). 
1.3.4 Prostaglandins and cell differentiation 
Much work is now focusing on the role of prostaglandins in cell differentiation. 
It has been demonstrated that inducer-induced cell differentiation is associated with 
the production of prostaglandins. Treatment of 3T3-L1 preadipocyte with PGF2„, 
PGE2 and PGD2 resulted in a dose-dependent inhibition of adipocyte differentiation. 
The inhibition of differentiation was reversed by the addition of cyclooxygenase 
inhibitor ibuprofen or indomethacin (Long and Pekala, 1996，Casimir et al., 1996). 
Two independent mechanisms including the oxidative metabolism to the 
cyclooxygenase metabolite and the subsequent elevation of cAMP levels may be 
involved. 
Another example is the mouse myeloid leukemia Ml cells. When this cell 
line was induced to differentiate into mature macrophage and granulocytes by 
various inducers, the differentiated cells synthesized and released prostaglandins, 
predominantly PGE:，PGD: and PGF2„ (Honma et al., 1980). The subtype of PGs 
produced was related to the maturity of the cell. PGE2 seems to be produced by the 
mature cells. 
The role of PG has also been demonstrated in human cell model. When the 
human myeloid cell lines (K562, HL60 and U937) were exposed to human T-cell 
leukemia vims type-1 (HTLV-1), a delayed growth rate was observed in infected 
cells. PGAi and PGJ2 exerted similar effect by inducing growth arrest prevalently 
at the Gl/S interphase of the cell cycle (Lacal et al., 1994). The antiproliferative 
effect of PGs increased progressively from pluripotent K562 to promyelocytic HL60 
and monoblastoid U937 (Lacal et al., 1994). The results indicate that differentiated 
cells are more susceptible to PG-mediated inhibition of growth than pluripotent cell. 
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Human promonocytic leukemia cell, the THP-1 human monocytes, when 
induced to differentiate by 12-0-tetradecanoyl-phorbol-13-acetate (TPA), was found 
to have an increase in the production of PGH synthase and prostaglandins (Smith et 
al” 1997). This phenomenon was also observed in promonocytic cell line treated 
with other inducing agents (Smith et al” 1997). 
Prostaglandins with an a , (3 unsaturated ketone ring structure were shown to 
inhibit cell growth (Hughes-Fulford, 1997). The cyclopentenone structure of PGs 
was believed to be essential for cell growth inhibition. The growth inhibitory 
activity could be dissociated from other biological activities of PGs (Fukushima et 
al” 1982a). Mechanistic studies showed that PGs receptors play a crucial role in 
regulating the cellular response. Fos and Jun, the major constituents of activator 
protein-l(AP-l)，were found to be induced by PGE? through the action of EP 
receptors in NIH 3T3 cells (Simonson et al” 1997). PGE? has been shown to 
induce a marked and transient accumulation of c-fos mRNA via the cAMP 
dependent mechanism. In MC373 osteoblast cell line, PGE2 was found to induce 
immediate-early genes and actin gene expression, and the c-fos transcript message 
was increased by at least 20 folds (Hughes-Fulford, 1997). 
There are also indirect evidence showing the involvement of prostaglandins in 
regulating cell differentiation. Indomethacin can inhibit 3a-hydroxysteroid 
dehydrogenase and decreases the production of prostaglandins. The inhibition was 
associated with an enhanced sensitivity of HL-60 to physiological differentiating 
agents like dll-trans retinoic acid, 9-cis retinoic acid, l a , 25-dihydroxyvitamin D3 
and G-CSF (Bunce et al., 1996). Indomethacin potentiated Dg-induced monocytic 
differentiation of HL-60 cells may also be accounted by the decreased production of 
prostaglandins. It thus indicates that the actions of prostaglandins can be varied 
among different cell lineage and cell stages. 
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There were various reports showing the relationship between PGs and cell 
proliferation and cell differentiation. Among those PGs being investigated, PGD2 
PGE2 and PGJ2 were mostly studied. These three types of PGs will be discussed in 
the following sessions. 
1.3.4.1 PGD2 and cell differentiation 
PGD2 is a potent inhibitor to induce platelet aggregation in vitro. It is 
involved in smooth muscle contraction or relaxation. PGD2 has been implicated in 
a variety functions of central nervous system (CNS)，these include synaptic 
transmission, hypothalmic control of temperature, recovery from seizures and the 
release of luteinizing hormone (White et al” 1992). Two kinds of prostaglandin D 
synthase (PGD synthase) have been reported, and they are distinguished by the 
dependence of glutathione. They are the glutathione (GSH)-independent type (also 
known as the lipocalin-type or brain type PGD sythase) and the GSH-dependent 
type (also known as haemopoietic enzyme). 
The brain type PGD synthase is thought to be involved in the induction of 
sleeping. Various agents strictly regulate both type of PGD synthase. 
Interestingly, those regulating agents may be involved in haemopoiesis either 
directly or indirectly. During rat brain development, thyroid hormone could affect 
PGD synthase expression and such controlling effect could be more related to the 
developmental processes (Garcia-Fernandez et al., 1993). Cytokines like IL-3，IL-
9 and IL-10 each could enhance the c-kit ligand (KL)-induced expression of 
prostaglandin endoperoxide synthase-1 (PGHS-1), and KL alone could stimulate the 
increased expression of cytosolic phospholipase A � (cPLA?)，PGHS-1 and 
haemopoietic type PGD synthase. This finally led to an increase in level of PGD2 
(Murakami et al., 1995). 
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TPA, a well-known chemical inducing agent, can also regulate the 
haemopoietic PGD synthase in megakaryocytic cells. A higher expression level of 
PGD synthase was found in less mature megakaryocytes and thus the expression of 
the enzyme was related to the maturation of megakaryocytes (Suzuki et al” 1997). 
Recent study shows that brain type PGD synthase binds with dlX-trans- or 9-cis-
retinoic acid and diW-trans or 13-ci5-retinal, and functions as a retinoid transporter 
(Tanaka et al； 1997). PGD synthase is thus being considered as a bifunctional 
protein with both retinoid transporting and PGD2- producing activities. Since 
retinoic acid is often used in the differentiation therapy, its regulation on PGD2 
synthesis may lead to an assumption that PGD2 production also got involved in such 
induced-differentiation process, most probably located at the downstream part. 
Results from previous studies showed that PGD2 solely exerted a dose 
dependent inhibition of L1210 mouse leukemia cell growth (Fukushima et al” 
1982b). The same effect was also observed in human leukemia cell lines such as 
NALL-1, RPMI-8226，RPMI-8402 and SK-Ly-16 (Fukushima et al., 1982b). In 
normal mast cells, basophils and even leukemia cells like RBL-1 cells, PGD2 was 
the major cyclooxygenase product being produced (Steinhoff et al” 1980). For 
cultured mast cells induced from cord blood mononuclear cells by steel factor, IL-6 
and PGE2, PGD2 was also released upon stimulation with IgE- anti IgE challenge 
(Obata et al； 1996). The results indicate that PGD2 may play a role in controlling 
cell growth and cellular functions. 
1.3.4.2 PGE2 and cell differentiation 
PGE2 is mainly synthesized by macrophage, follicular dendritic cells and 
fibroblasts (Brown and Phipps，1997). Just like other prostaglandins, the actions of 
PGE2 are diverse and the distribution varies among tissues. PGE2 induces water 
reabsorption in the renal collecting tubule through its receptor coupled to a Gi to 
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attenuate arginine vasopression-induced cAMP synthesis (Nakao et al., 1989, 
Sonnenburg et al., 1990). It also influences the growth of different cell types. 
One of the examples is the formation of osteoclasts. Osteoclasts are formed by 
fusion of precursors that are derived from the pluripotent haemopoietic stem cells. 
PGE2 acts directly on circulating osteoclast precursors to influence osteoclast 
differentiation (Itonaga et al； 1999). 
PGE2 has also been shown to act as a potent modulator of osteoblast 
proliferation. It could inhibit proliferation of UMR 106-01，a rat osteogenic 
sarcoma cells through the activation of both cAMP-dependent protein kinase-A 
(PKA) and the Ca" /diacylglycerol/protein kinase-C (PKC) signal transduction 
pathway (Fang et al” 1992). Expressions of c-fos and c-jun mRNA were also 
induced under the influence of PGE2. Low levels of PGE2 promote costochondral 
chondrocyte differentiation by increasing the cAMP production and protein kinase C 
activity in a cell maturation-dependent manner (Schwartz et al” 1998). 
In Swiss 3T3 fibroblasts, arachidonic acid exerted its stimulatory effect on the 
expression of c-fos and egr-1 mRNA via the synthesis of PGE2 and subsequent 
activation of protein kinase C, probably through a PGE2 receptor coupled to 
phospholipase C. jun b mRNA in Syrian hamster embryo fibroblasts was also 
increased after the induction of PGE2 (Danesch et al., 1994). 
PGE2 was considered to be a major regulator in the marrow microenvironment. 
PGE2 regulates macrophage production mainly by inhibiting macrophage formation 
at the progenitor cell level (Williams and Jackson, 1980). It also acts as an 
autocrine mediator to stimulate the differentiation of uncommitted macrophages into 
insulin-like growth factor-1 (IGF-1) producing cells (Fournier et al., 1997). Dose-
dependent inhibition of normal marrow CFU-GM and circulating CFU-GM from 
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bone marrow of patient with CML were observed after PGE2 treatment (Richman 
and Johnson, 1987). Murine B cell lymphomas were growth-inhibited and 
ultimately killed by a mechanism of apoptosis after PGE2 treatment (Brown and 
Phipps, 1997). 
Similar to PGD〗，PGE� interacts with other cytokines. Exogenous PGE: was 
found to mediate a dose dependent suppression of lipopolysaccharide (LPS)-induced 
TNF mRNA via transcriptional regulation (Kunkel et al., 1988). The switching of 
biosynthesis of PGD: to PGE2 is under the influence of TNF-a (Fournier et al., 
1997). 
The application of PGE2 in the cytodifferentiation therapy has also been 
examined. CML was resistant to the inhibitory effects of PGE” It has been 
attributed to a fewer HLA-DR+ CFU-GM in CML, as the inhibitory effect of PGEi 
on normal CFU-GM appears to be restricted to those HLA-DR expressing cells 
(Cannistra et al” 1986). It is worth to investigate the potential of PGE2 in inducing 
differentiation of other types of leukemia. 
1.3.4.3. PGJ2 and cell differentiation 
Under physiological pH and temperature, PGD2 spontaneously decomposes to 
9-deoxy-A^-PGD2 and the degradation product is designated as PGJ2 PGJ2 was 
found to inhibit proliferation of cultured vascular smooth muscle cells, mouse 
melanoma cells and mouse fibroblasts (Mahmud et al., 1984). In L-1210 murine 
leukemia cells, was the ultimate metabolite exerting growth inhibition. 
The action appeared to be independent of cAMP, since was virtually 
inactive in raising intracellular cAMP levels (Narumiya and Fukushima, 1985). 
The accumulation of PGJ2 in the cytoplasm and nuclei may also account for its 
growth inhibitory activity (Narumiya and Fukushima, 1986). As PGJ2 is more 
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potent than PGD: in inhibiting proliferation of L1210 leukemia cells (Fukushima et 
al., 1982a), it is believed that the inhibitory effect of PGD2 may be due to the action 
ofPGJ^. 
In general, prostaglandins like PGD2 and PGE2 exert their actions by acting on 
cell surface receptors. However, there is no cell surface receptor for PGJ2. PGJ2 
is transported directly into the cell and accumulates in the nuclei. In rat basophilic 
leukemia cells，A^^ -PGJ2 induced the expression of the rat ho-1 gene through the 
binding of nuclear protein to a specific element having an E-box motif (Koizumi et 
al., 1995). When more studies were carried out, it was found that PGJ2 derivatives 
were the natural ligands of peroxisome proliferator-activated receptors (PPAR) type 
Y-
There are 3 types of PPAR, namely PPAR-a, (3, and y. They all belong to the 
nuclear receptor superfamily. Among the 4 classes of nuclear receptor families, 
PPAR are class II receptors which consist of the thyroid receptor (TR), retinoic acid 
receptor (RAR) and the vitamin D receptor (VDR). The PPAR control the 
expression of genes implicated in intra- and extracellular lipid metabolism, such as 
the peroxisomal P-oxidation. PPAR heterodimerize with retinoic X receptor (RXR) 
and alters the transcription of target genes after binding to response elements 
(Schoonjans et al., 1996a，1996b). 
Being the activating ligand for PPAR-y, PGJ2 plays a central role in promoting 
adipogenesis. PGF^a also regulates adipogenesis through the activation of 
mitogen-activated protein kinase, which results in an inhibitory phosphorylation of 
PPAR-y. This indicates that PG signals generated at a cell surface receptor can 
regulate the program of gene expression, especially the genes required for 
adipogenesis by modulating the activity of a nuclear hormone receptor activated by 
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other PG signals (Reginato et al” 1998). The phosphorylation of PPAR-y may also 
affect the expression of CD36，the macrophage type B scavenger receptor (Han et al., 
2000). 
It is clear that PGJ2 exerts its effect through the activation of PPAR-y. Though 
this receptor is closely related to adipogenesis，it may also regulate differentiation of 
other cell types. 
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1.4 WEHI-3B JCS cells 
To investigate the haemopoiesis, it is easier to start with the studies of a 
particular leukemia cell line. The murine myelomonocytic leukemia cell line 
WEHI-3B JCS has been used as a model in the study of myeloid leukemia (Leung et 
al., 1994). The disease that the WEHI-3B caused when injects into mice appears to 
resemble human acute myeloid leukemia (Camba-Vitalo, et al., 1989). The 
cytokine G-CSF has been demonstrated to induce terminal differentiation of WEHI-
3B cells (Nicola et al； 1983). 
WEHI-3B was divided into the D+ and D subgroups based on the different 
response induced by G-CSR The WEHI 3B (D+) cells produce differentiated 
granulocyte-macrophage colonies in the presence of post-endotoxin serum or 
recombinant G-CSF while the D subclone has no response. A subclone (JCS) of 
the WEHI-3B (D") cells was further isolated. This cell clone was unresponsive to 
G-CSF and it acquired the characteristics of mature macrophage in the presence of 
PMA or non-cytotoxic concentrations of TNF-a (600-1200 U/ml) (Mak et al., 
1993). 
IL-4 was found to act synergistically with TNF-a to inhibit cell proliferation 
and to induce monocytic differentiation of JCS cells (Leung et al” 1994). 
Nobiletin and tangeretin, active components found in the extracts prepared from the 
pericarpium of Citrus reticulata, inhibited the proliferation of JCS cells in a dose 
dependent manner. The cells were also induced to differentiate into macrophages 
and granulocytes (Mak et al., 1996). When JCS cells were treated with biochanin 
A，the cell showed increased phagocytic activity and the expression of macrophage 
differentiation markers Mac-1 and F4/80 was up-regulated. The growth of JCS 
cells was inhibited under the effects of biochanin A (Fung et al., 1997). 
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Monocytic differentiation of JCS cells was accompanied by a loss in the ability 
of the cells to form clonogenic colonies in vitro and differentiated JCS cells also had 
reduced tumorigenic capacity (Leung et al., 1994). As JCS cells can be induced to 
differentiate into cells of monocytic and granulocytic lineage, molecular studies of 
the induced differentiation of the cells may provide some insights in understanding 
the mechanism of myeloid differentiation. 
The expression of cytokines mRNA during biochanin A induced JCS cell 
differentiation was investigated. IL-la, IL-lp and IL-4 appear to act on the later 
stage of monocytic differentiation (Fung et al., 1997). The differential gene 
expression during TNF-a induced JCS cell differentiation was also examined 
recently. Some differential genes like prostaglandin D synthetase, calpain small 
subunit, beta-2 microglobulin, Ac39/physophilin and cystatin C were found not only 
related to the leukemia cell differentiation but also the embryo development (Chan 
et al., 1998). As the complexity of haemopoiesis is far from our imagination, large 
amount of data still needs to be collected in order to have a clear picture of the 
process. 
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1.5 Aims of study 
Haemopoiesis is a highly complex and coordinated process. The production 
of blood cells is vital for us and the fail of this process can lead to leukemia. 
Nowadays different kinds of therapy are used to cure the disease, and 
cytodifferentiation therapy is one of them. Before knowing how to deal with the 
disease, it is important to understand the underlying mechanism of haemopoiesis. 
This may not only enhance our knowledge about our body but also provide a clear 
direction in developing the cytodifferentiation therapy. 
Both of the stromal environment and the haemopoietic regulators are 
responsible for the regulation of haemopoiesis. Prostaglandin is a group of the 
elements found in the stromal environment and is thought to be a potential 
haemopoietic regulator. Studies also revealed the role of prostaglandin in cell 
differentiation and proliferation. By studying the action of prostaglandin upon 
haemopoietic cells, it is hoped that some clues can be found about haemopoiesis. 
The WEHI-3B JCS is a mouse myeloid leukemia cell line which can be induced to 
differentiate into cells of both monocytic and granulocytic lineage. The effect of 
prostaglandin on normal bone marrow cells is also worth noting. 
The genetic regulation of haemopoiesis is still poorly understood. The 
comparison of gene expression profile between cells induced to differentiate and the 
control cell is one of the approaches to get some more information. By analyzing 
the action of prostaglandin on JCS and bone marrow cells differentiation and 
proliferation, the mechanistic action involved in lineage preference in haemopoiesis 
is hope to know. Besides, the possible application of prostaglandins as anti-
leukemia drug is also examined. 
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Chapter Two Roles of Prostaglandin D】，E! and J2 in WEHI-3B 
JCS myeloid leukemia cell differentiation 
2.1 Introduction 
Prostaglandins, the prostanoids produced in our body，are involved in the 
regulation of various cellular and tissue functions. It is not surprising that 
prostaglandins also participate in the regulation of haemopoiesis. Previous studies 
shown that prostaglandins are involved in inducing cell differentiation, and the 
induction of differentiation is one of the methods to control the growth of leukemia 
(refer to section 1.3.4). This Chapter focuses on the studies to examine the anti-
leukemia action of prostaglandins. 
First，we evaluate the antiproliferative activity and the ability of different PG 
subtypes to induce the leukemia cell differentiation. Among the different kinds of 
prostaglandins, PGD2 PGE2 and PGJ2 were selected in this project to test for their 
effect on a myeloid leukemia JCS cell line. These three types of prostaglandins 
were chosen because their antitumor activities were reported previously (refer to 
section 1.3.4). Then, their effects on the growth of JCS cells and the changes 
brought to the cells were determined. Besides, as to understand more about the cell 
line, morphological studies of the cells were done. 
2.1.1 Morphological studies of JCS cells 
To determine the morphological differentiation of JCS cells, both light 
microscopy and transmission electron microscopy (TEM) were used. The light 
microscopy provides a general appearance of the stained cells. As the cells are tiny, 
colorless and translucent, staining is required to show the staining properties of the 
cytoplasm and other cellular structures. 
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Transmission electron microscopy (TEM) is used to study the internal ultra-
structure of the cells. It provides the image of each individual organelle. Similar 
to the principle of scanning electron microscopy (SEM)，a thin film of heavy metal 
is evaporated onto the dried specimen and a shadow effect is created which gives the 
three-dimensional image (Alberts et al., 1994). TEM gives a higher resolution and 
is suitable to observe the details of the internal organelles. Detailed information of 
the cells is thus obtained through the use of light and electron microscopy. 
2.1.2 Methods in determining cell proliferation 
Most of the anti-leukemia drugs inhibit the growth of tumor cells. The 
antiproliferative activities of prostaglandins on the proliferation of JCS cells are 
determined. Various methods are available to determine the degree of cell 
proliferation. Traditionally, visual methods are used to check the number of dead 
cells. Among them, vital dyes (eg. Trypan blue) are often used to stain the dead 
cells. Some other methods identify the dividing cells during the incubation with 
the drugs. These methods based on the fact that cellular proliferation is 
accompanied with the replication of cellular DNA. The monitoring of DNA 
synthesis thus acts as a mean to determine the degree of cell proliferation. 
Biochemical measurement of the metabolism of cells also provides an indirect 
approach to measure the cell growth and a comprehensive comparison review has 
been reported by Mather and Barnes (Mather and Barnes, 1998). This section will 
only list out and compare the strengths and weaknesses of several selected methods. 
The use of vital dyes 
Trypan blue is the most commonly used vital dye in the staining of dead cells. 
It is based on the fact that the cell membrane of a living cell is able to exclude the 
dyes. On the contrary，dead cells with compromised cell membrane loss the ability 
to exclude the dye and thus are stained positively (Mather and Barnes, 1998). The 
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staining process with trypan blue is easy to perform and the cells can be observed 
directly under the bright field microscope. But it is very time consuming when 
handling a number of samples. Moreover, the counting needs to be done within a 
few minutes as prolonged exposure to the dye may cause cell death. The counter 
error could be enormous if the cell density is not properly controlled. 
pH]-thymidine incorporation assay 
In this method, [^H] -methy 1-thymidine is used to label the DNA of mitotically 
active cells. Cell proliferation is measured by the degree of mitosis. Ihe method 
is sensitive and commonly used. Cells that incorporate [^H] -methyl-thymidine 
during a brief pulse are identified autoradiographically. In case of cultured cells, 
the cells are harvested and the radioactivity was determined using a liquid 
scintillation counter. As radioisotopes are used，it needs to be handle carefully and 
disposal problems should be solved. Specialized equipment like a cell harvester 
and liquid scintillation counter are required. 
BrdU incorporation assay 
5-bromo-2'-deoxyuridine (BrdU) is a relatively new method. The method is 
similar to the [^H]-thymidine incorporation assay. It is based on the incorporation 
of the pyrimidine analogue BrdU instead of [^ H] -methyl-thymidine into the DNA of 
proliferating cells. After its incorporation into DNA, BrdU is detected by 
immunoassay. Colorimetric immunoassay is commercially available. This 
method is safe to perform. Data is obtained by measuring the absorbance of the 
reaction products at respective wavelength using a scanning multiwell 
spectrophotometer (ELISA reader). Though it is convenient to use, some practical 
problems still need to be overcome. Lots of washing steps in this method may lead 
to cell lost and the result is not consistent. High background is also one of the 
major problems and the experimental conditions are required to be adjusted 
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carefully. This method works best for the adherent cell lines. 
MTT assay 
The MTT [3-(4，5-dimethylthiazol-2-yl)2，5-diphenyltetrazolium bromide] assay 
measures the ability of mitochondria to convert the tetrazolium salt MTT into a 
colored foraiazan product that can be measured spectrophotometrically. This 
method bases on the idea that growing cells will have respiratory-competent 
mitochondria and can actively convert MTT to formazan. When MTT is added to 
the cell cultures, MTT is converted to formazan, and lysis buffer is used to solubilize 
the water-insoluble formazan. The MTT assay is easy to perform and there are 
only a few steps to perform. This method measures the degree of metabolism of 
tetrazolium salts by NAD-dependent dehydrogenase activity and it is thus an 
indirect method to measure metabolically active cells. 
In this project, the degree of cell proliferation is determined using [^ H -
thymidine incorporation assay and the MTT assay. It is because the results 
obtained from the j^H]-thymidine incorporation assay are more accurate and 
reproducible. Since radioactive stuff is used in this method, MTT assay is also 
adopted and the results obtained from both methods are compared. 
2.1.3 Methods in determining differentiated cells 
Both morphological examination and the expression of cell surface antigens 
can be used to determine the differentiation of PG treated leukemia cells. 
Cell morphology 
The simple method to distinguish different cell types is to study their 
morphology. When the stem cells become more mature and committed to 
differentiate into specific cell lineage, the maturing cells are readily identified by 
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their cytological properties. For example, polymorphonuclear leucocytes are 
characterized by the presence of multilobed nucleus. Most often, the cell 
morphology is examined using cytocentrifuge preparations. The cytoplasm and 
nucleus of the cells are stained and different stages of the cells are scored. 
Functional activity of the cell 
Mature cells acquire distinct functions. For example, mature macrophages 
and granulocytes are phagocytic cells, and are able to engulf and destroy invading 
microorganisms. The phagocytic activity of the cell indicates the state of cell 
activation. Nitroblue tetazolium dye (NBT)-reducing activity is also a 
differentiation-associated characteristic. 
Flow cytometry 
Flow cytometric analysis can be used to detect the expression of cell surface 
antigens of the differentiated cells. Since different cell surface antigens are 
expressed at different stages of maturation, and the cell surface markers can be used 
to identify the cell types. Cells can be stained with specific primary monoclonal 
antibodies (mAbs) followed by fluorescein isothiocyanate-conjugated secondary 
mAbs. Alternatively, the cells can be stained directly with fluorescein 
isothiocyanate-conjugated primary mAbs. The evaluation of the expression of 
surface markers of the cells is achieved by measuring the fluorescent signals using a 
fluorescence- activated cell sorter (FACS) (Mather and Barnes, 1998). 
In this project, the degree of cell maturity is determined using the histochemical 
staining method. Cells at different stage of maturation were scored. 
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2.2 Materials 
2.2.1 Cell line 
WEHI 3B (JCS) myeloid leukemia cells (Mak et al., 1993) subclone was 
provided by Dr. N.K Mak in the Department of Biology，the Hong Kong Baptist 
University. The cell line was maintained in RPMI-1640 medium supplemented 
with 10 % heat-inactivated fetal bovine serum (FBS, GibcoBRL), 2 mM glutamine, 
50 U/ml penicillin，50 \i\ /ml streptomycin, and 10 [ig/ml neomycin. Cells were 
incubated at 37 in a 5 % CO2 atmosphere. 
2.2.2 Chemicals 
1. Canada balsam Sigma CI 795 
2. Diethyl pyrocarbonate Sigma D5758 
3. Ethanol Sigma D5758 
4. Fetal bovine serum GibcoBRL 16000-044 
5. 25 % Glutaraldehyde EMS 16200 
6. Hemacolor solution 1 Merck 1.11955 
7. Hemacolor solution 2 Merck 1.11956 
8. Hemacolor solution 3 Merck 1.11957 
9. Hydrochloric acid, 36 % (HCl) Ajax 1364 
10. Lauryl sulphate (SDS) Sigma L5750 
11. Lead nitrate Sigma L6258 
12. Methanol Ajax 723 
13. Osmium tetroxide (OSO4) EMS 19130 
14. Penicillin-streptomycin-neomycin (PSN) GibcoBRL 15640-055 
15. Potassium chloride (KCl) Sigma P4504 
16. Potassium phosphate, monobasic (KH2PO4) Sigma P5379 
17. Prostaglandin D2 (PGD2) Sigma P5172 
18. Prostaglandin E: (PGE2) Sigma P5640 
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19. Prostaglandin (PGjy Sigma P9807 
20. RPMI-1640 medium GibcoBRL 23400-021 
21. Sodium bicarbonate Sigma S5761 
22. Sodium chloride (NaCl) Sigma S3014 
23. Sodium citrate Sigma S4641 
24. Sodium hydroxide (NaOH) Sigma S8045 
25. Sodium phosphate, dibasic (NazHPO*) Sigma S0876 
26. Sodium phosphate, monobasic (NazHPO*) Sigma S0751 
27. Thiazolyl blue (MTT) Sigma M5655 
28. Uranyl acetate Ernest F. Fullam 5019 
2.2.3 Solutions and buffers 
1 Cell lysis buffer 10 % SDS in 0.01 N HCl 
2 2.5 % glutaraldehyde in phosphate 1 glass of glutaraldehyde in 90 ml 
buffer phosphate buffer 
3 Methanolic uranyl stain 0.25 g uranyl acetate in 20 ml methanol 
4 MTT solution 4 mg Thiazolyl blue in 1 ml phosphate 
buffered saline. Solution being filtered. 
5 1 M NaOH 1 gm NaOH in 25 ml distilled H2O 
6 Phosphate buffered saline (PBS) 8 g NaCl, 0.2 g KCl, 1.44 g Na2HP04 and 
0.24 g KH2PO4 in 1 L H^O, adjust to pH 7.4 
by NaOH 
7 Phosphate buffer (PB) 36 ml Solution A, 14 ml Solution B mixed 
with 50 ml distilled H p 
8 10 mM Prostaglandin D^ 1 mg PGD: dissolved in 284 absolute 
ethanol 
9 10 mM Prostaglandin E2 1 mg PGE^ dissolved in 284 i^l absolute 
ethanol 
10 10 mM Prostaglandin J^  1 mg PGJ^ dissolved in 299 |LI1 absolute 
ethanol 
11 Reynold's lead citrate stain 2.01 gm sodium citrate.ZH^O，1.33 gm lead 
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nitrate in 30 ml distilled H2O and 8 ml 1 M 
NaOH 
12. 1 X RPMI-1640 medium 1 package of RPMI powder dissolved in 1 L 
milli-Q water. 2 gm of sodium bicarbonate 
was added and the solution was adjusted to 
pH 7.2 with 1 M NaOH. Medium being 
filtered. 
12 RPMI complete medium 1 X RPMI 1640 medium supplemented with 
10 % FBS and 1 % PSN 
13 Solution A 7.1 gm Na2HP04 in 250 ml distilled H2O 
14 Solution B 3.9 gm NaHsPC^ I R f i in 125 ml distilled 
H2O 
15 Spurr solution Mixture of 2.5 g Vinyl cyclohexene dioxide， 
1.5 g DERt36 epoxy resin, 6.5 g Nonenyl 




2.3.1 Microscopic studies of the JCS cells 
2.3.1.1 Histochemical staining of JCS 
The cells were examined on cytocentrifuge preparations. About 5 x lO* 
induced cells were centrifuged onto a clean slide by using the Shandon Cytospin 3 
centrifuge (Shandon Scientific). Cells were fixed in Hemacolor 1 for 5 seconds, 
stained in Hemacolor 2 for 15 seconds and counterstained in Hemacolor 3 for 10 
seconds. After rinsed with running water, the slides were air-dried and were 
mounted with Canada Balsam. Cells were categorized as blast cell, intermediate 
stage, metamyelocyte, macrophage and polymorphonuclear neutrophil (PMN) 
according to the cytological features of the cells. Six hundred of cells were scored 
for each test sample and the results are expressed as mean 土 standard error. 
2.3.1.2 Transmission electronic microscopy 
Cells were first harvested by centrifugation at 700 X g for 5 minutes. The 
cells were then washed twice with PBS and fixed in 2.5 % glutaraldehyde solution at 
4 °C for 2 hours. The cell pellet was minced into 1 mm cubes with a sharp blade. 
After washed with PB, the cell cubes were post-fixed in 1 % OSO4 for 2 hours. 
Another washing with PB was carried out and the cell cubes were then dehydrated in 
a graded series of ethanoL Infiltration with spurr solution was then performed 
afterwards until the cell cubes were totally embedded in pure spun solution. 
The cell cubes were cut into thin sections using an ultra-microtome (Reichert). 
The sections were fixed on grids and stained with uranyl acetate for 15 minutes, 
washed with distilled water, and stained with lead citrate for another 15 minutes. 
After a thorough wash in distilled water, the grids containing cells sections were 
kept dried and the sections were viewed with a transmission electron microscope. 
All micrographs were took under JEM-1200 EX II. 
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2.3.2 pH]-thymidine incorporation assay 
This experiment was performed by Ms. S.Y. Chan. She was the senior 
seminar student of Dr. N.K. Mak in the Department of Biololgy，the Hong Kong 
Baptist University. 2 x 10^ JCS cells were incubated in 200 \i[ of RPMI complete 
medium containing various concentrations of PGD?，PGE: and PGJ? at 37 for 48 
hours in a humidified CO2 incubator (5 % CO2 in air). After 42 hours of incubation, 
cells were pulsed with 0.5 fxCi of [^H]-methyl thymidine ([^H]TdR) for 6 hours. 
The cells were harvested and the incorporated radioactivity was measured using a 
liquid scintillation counter. 
2.3.3 MTT assay 
2 X 10^ JCS cells were cultured with different concentrations of PGD?，PGE? 
and PGJ2 in wells of the 96-well flat bottom plates (Corning). The mixtures were 
incubated at 37 for 72 hours. Each dilution was prepared in triplicate. After 
incubated for 72 hours, 25 \i\ of MTT solution was added into each culture and the 
cultures were incubated for another 4 hours. 100 \il of culture medium was 
replaced with 100 of cell lysis buffer to solubilize the formazan. Optical density 




2.4.1 Histochemical staining of JCS cells 
Figure 2.1 shows the typical histochemical staining of JCS cells. Figure 2.1 
shows the general appearance of stained normal JCS cells. The cell has higher 
nucleus to cytoplasm ratio (N/C ratio). Cells from older culture (three days culture) 
were also examined and auto-differentiation of cells was observed. In figure 2.1 B 
shows the cells at different stage of differentiation. The cells generally have a 
higher cytoplasm/ nucleus ratio (N/C ratio). Note the doughnut shaped nucleus of 
metamyelocyte and the bilobed nucleus of PMN cells. The C/N ratio was greatly 
increased in mature macrophage. 
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Figure 2.1 Cell morphology studies of WEHI-3B JCS cells. (A) Two days 
culture of JCS cells, a: blast cell. (B) Three days culture of JCS cells, b: 
intermediate stage, c: metamyelocyte, d: polymorphonuclear leukocyte and e: 
macrophage. JCS cells were grown in RPMI complete medium and examined on 
cytocentrifuge preparations. Cells were stained with Hemacolor. 
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2.4.2 Electron microscopy 
Internal structures of the JCS cells were investigated. Three-day-old JCS cells 
were prepared and observed under transmission electron microscope. 
Figure 2.2 shows the typical electron micrograph of an undifferentiated JCS 
cells. The cell contains a large nucleus and has little cytoplasm (Murphy et al., 
1978). 
Figure 2.3 indicates a cell showing differentiation towards granulocytic lineage. 
This cell image was similar to a band neutrophil. During differentiation into a 
mature neutrophil, the nucleus of the cell may change from large, round and 
euchromatic to small, band-shaped and heterochromatic nucleus with 3-5 lobes in 
the mature cell. 
The cell shows in figure 2.4 bore the characteristic cytoplasmic condensation, 
chromatin condensation and segregation of an apoptotic cell. 
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Figure 2.2 Transmission electron micrograph of an undifferentiated JCS cell. 
The cell was stained with uranyl acetate and lead citrate. Photo was taken under 
JEM-1200 EXII (refer to method 2.3.1.2) and cell was magnified for 6000 X. 
Key: (a) nucleus, (b) mitochondrion, (c) lysosome. 
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Figure 2.3 Transmission electron micrograph of a differentiated JCS cell towards 
granulocytic lineage. The cell was stained with uranyl acetate and lead citrate. 
Photo was taken under JEM-1200 EXII (refer to method 2.3.1.2) and cell was 
magnified for 6000 X 
Key: (a) nucleus, (b) granule 
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Figure 2.4 Transmission electron micrograph of a JCS cell undergoing apoptosis. 
The cell was stained with uranyl acetate and lead citrate. Photo was taken under 
JEM-1200 EXII (refer to method 2.3.1.2) and cell was magnified for 6000 X. 
Key: (a) nucleus, (b) mitochondrion, (c) chromatin condensation 
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2.4.3 Effect of PGD】，E! and J2 on JCS cells proliferation 
From the [^H]-thymidine incorporation assay performed by Ms. S.Y. Chan, the 
IC50 of PGD2，PGE2 and PGJ2 on the JCS cell is 1.81 ！iM, 1.2 nM and 11.3 \iM 
respectively. The concentrations of PG being examined were ranged from 0.048 
i^M to 25 \iM. The three PGs were all shown to inhibit cell growth in a dose 
dependent manner. 
Cytotoxicity of the three PGs on JCS cells was also examined using MTT assay. 
Optical density at wavelength of 570 nm (OD570nm) was measured. The higher the 
value of OD570nm，the more viable cells are present in the culture. The effect of 
ethanol on JCS cells was also determined as the stock PG solution was prepared in 
ethanol. PGs were subsequently diluted with RPMI-1640 medium and serial 
dilutions were made. Data of the MTT assay for PGD:，PGE2 and PGJ2 are 
presented in Figure 2.5，2.6 and 2.7 respectively. 
Figure 2.5 shows the dose-dependent inhibition of JCS cells by PGD?. The 
IC50 of PGD2 on JCS cells was 7.2 ^iM. PGE^ exerts a greater inhibitory effect on 
the JCS cells. The IC50 of PGE2 on JCS cells was 6.5 nM. In contrast, PGJ� was 
the less potent one to inhibit cell growth (IC50 > 25 ^iM). 
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Figure 2.5 Effect of PGD? on JCS cells. 2 x 10^ JCS cells were cultured in 
wells of 96-well plate and incubated with different concentrations of PGD: at 3 7 � C 
for 72 hours. After incubation, cells were incubated with MTT and the formazan 
was dissolved in lysis buffer. OD^JQ^^ of each sample was measured. Each 
dilution was prepared in triplicate and the test range was from 0.049 i^M to 25 \iM. 
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Figure 2.6 Effect of PGE? on JCS cells. 2 x 10^ JCS cells were cultured in 
wells of 96-well plate and incubated with different concentrations of PGE� at 3 7 � C 
for 72 hours. After incubation, cells were incubated with MTT and the formazan 
was dissolved in lysis buffer. of each sample was measured. Each 
dilution was prepared in triplicate and the test range was from 0.049 i^M to 25 [xM. 
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Figure 2.7 Effect of PGJ2 on JCS cells proliferation. 2 x 10^  JCS cells were 
cultured in wells of 96-well plate and incubated with different concentrations of 
PGJ2 at 37 for 72 hours. After incubation, cells were incubated with MTT and 
the formazan was dissolved in lysis buffer. OD570細 of each sample was measured. 
Each dilution was prepared in triplicate and the test range was from 0.049 piM to 25 
i^M. 
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2.4.4 Effect of PGD ,^ E! and J! on JCS cells differentiation 
JCS cells were incubated with different concentrations of PGD^，PGE2 and 
PGJ2 for 3 days. Cytospin preparations were made and cells were stained with 
Hemacolor solution. The number of blasts, cells at intermediate stage, 
metamyelocytes, macrophages and PMN was determined. Six hundreds of cell 
were scored for each sample and the results are expressed at means 土SD. 
Table 2.1 shows the differentiation inducing effect of PGD2 on the JCS cell. 
At the concentration of 25 i^M of PGD2, about 60 % of cells were slightly 
differentiated into intermediate stage and only 1 % of macrophages was seen. 
When the same concentration of PGE2 was added to the JCS culture, over 70 % of 
cells were induced to differentiate into macrophage while only a small portion of 
PMN was found (Table 2.2). The result for PGJ2 (Table 2.3) was similar to that of 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.5.1 Morphological differentiation of JCS cells 
In order to study the cell differentiation, JCS cells were first fixed and stained 
by the hemacolor solutions. Previously, the cells were stained with Wright's-
Giemsa (Mak et al., 1993). The use of commercial product Hemacolor provides a 
more efficient way to stain the cell. From the cytocentrifuge preparations, different 
stages of the JCS cells can be distinguished. These include cells at intermediate 
and mature stage. The degree of drug stimulation can be enumerated by counting 
the number of differenting cells. 
2.5.2 The ultra-structures of JCS cells 
To study the JCS cell under TEM，the procedure of the cell preparation has to 
be optimized. As the cells were grown in suspension, they should be centrifuged 
into a pellet before being fixed. The cells were washed and centrifuged for several 
times before fixation. The extensive washing may distort the cells. From the 
photos, it seems that cells were not fixed properly, and the membrane of the 
organelles were not so intact, and so the method and time for fixation still need to be 
modified. Maybe another way to perform the fixation part is to fix the cell prior 
the centrifligation. The conditions for postfixation in osmium tetroxide, staining in 
uranyl acetate, dehydration and embedding are all needed to be adjusted carefully. 
From the photos, some strip-like holes appeared. It is not certain if it is an 
artifact. It may be formed sectioning, or the embedding of spurr solution. To 
achieve a better result, a diamond knife of better quality should be used. 
Fortunately, the internal structures of the cells still could be seen (Figure 2.2-4). 
Cells at three different stage of differentiation were selected. The blast, the 
cell differentiated towards granulocytic lineage and the apoptotic cell. In the blast 
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cell, mitochondria, nucleus and lysosomes were clearly seen. The differentiating 
cell was similar to a band neutrophil. For cells undergoing granulopoiesis, the 
nucleus may change gradually from large, round to heterochromatic nucleus. 
Besides, one can also notice the formation of granules. From promyelocyte to 
myelocyte, metamyelocyte, band neutrophil and mature neutrophil (eg. PMN), 
secondary granules are formed and prominent golgi can also noticed. For the 
apoptotic cell, chromatin condensation is seen in the nucleus, and some of the 
internal structures were disintegrating. It was totally different with the previous 
two cells. 
2.5.3 Effect ofPGD^, PGE! and PGJ! on JCS cells proliferation 
Both [^H]-thymidine incorporation assay and MTT assay were used to 
determine the effect of the three PGs towards JCS proliferation. As shown in the 
section 2.4.3，[^H]-thymidine incorporation assay is more sensitive than MTT assay. 
The dose-response curves obtained from the two assays were similar (response 
curve from [^H]-thymidine incorporation assay was not shown), but since the two 
assays were measuring different parameters, differences of the IC50 values were 
noticed. [^H] thymidine incorporation assay determines the concentration of drug 
required to inhibit 50 % of [^H] thymidine incorporation. This is a direct method to 
measure cell proliferation. On the contrary, MTT assay determines the 
concentration of drug required to inhibit 50 % of the activity of mitochondria 
dehydrogenase. This is an indirect method and hence the IC50 generated from these 
two assays are different. 
The three types of PGs all exert a dose-dependent inhibitory effect on the 
growth of JCS cells. For PGD^, the I Q � v a l u e obtained in thymidine 
incorporation assay was 1.8 jiM. It was 1.2 nM and 11.3 i^M for PGE] and PGJ2 
respectively. It is obvious that PGE2 is more potent to inhibit the growth of JCS 
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cells. Previous study showed that PGD2 solely exerted a dose dependent inhibition 
of L1210 mouse leukemia cell growth (Fukushima et al., 1982b). The same effect 
was observed in human leukemia cell lines such as NALL-1，RPMI-8226, RPMI-
8402 and SK-Ly-16 (Fukushima et al； 1982b). Our results support these 
observations that PGD2 inhibits the growth of leukemia cells. 
Antiproliferative effect of PGE2 on haemopoietic cells has also been reported. 
It has been shown to inhibit the growth of normal marrow CFU-GM, circulating 
CFU-GM and bone marrow cells from patients with chronic myelogenous leukemia 
(Richman and Johnson, 1987). Our result also support the action of PGE2 being 
reported. 
Though PGJ2 is the metabolite of PGD], it was less potent in affecting JCS cell 
proliferation when compared with PGD2. In L1210 leukemia cells, PGJ2 was more 
potent than PGD: in inhibiting cell proliferation (Fukushima et al., 1982a). It was 
believed that the inhibitory effect of PGD2 was due to the action of PGJ2, and in our 
study, this was not the case. The discrepancy on the effects of PGJ2 on leukemia 
cells remains to be investigated. 
2.5.4 Effect ofPGD^, PGE^ and PGJ^ on JCS cell differentiation 
From the results, all of the three PGs could induce the JCS cells to differentiate. 
For PGD2, concentration of 25 i^M had led to 67.8 % of cells to slightly differentiate 
into intermediate stage (Table 2.1). Similar effect was observed for the PGJ2. 25 
i^M PGJ2 could drove 83.3 % of JCS cells to differentiate into intermediate stage 
(Table 2.3), and there was no indication of differentiation lineage preference. 
Though a small portion of metamyelocyte was observed, more cells were 
differentiated into mature macrophage. It is thus speculated that PGD? and PGJ2 
may have potential to drive cell to differentiate into monocytic lineage. 
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The differentiation pattern was clear for PGE? induced cells. When 25 piM of 
PGE2 was added to the JCS culture, as high as 74 % of cells differentiated into 
mature macrophage (Table 2.2). The cell differentiation lineage preference was 
also observed at lower concentration (7 nM) since 16 % of mature macrophage was 
found. Previous study had shown that PGE� could regulate macrophage production 
mainly by inhibiting the macrophage formation at the progenitor cell level (Williams 
and Jackson, 1980). Our result listed here contradict with this finding. In JCS 
cells, PGE2 seems to encourage macrophage formation and suppress the production 
of granulocyte. It is interesting to see whether PGE2 will act similarly in normal 
bone marrow cell. 
To understand the underlying mechanisms of the PGE2 induced JCS cell 
differentiation, we have analyzed the expression of PGE2 receptors and the genes 
involved at the early stage of differentiation. Results are presented in Chapter 
Three and Four. 
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Chapter Three Roles of Prostaglandin E! in normal haemopoiesis 
and the detection of PGE� receptors expression in JCS and bone 
marrow cells 
3.1 Introduction 
After investigated the effect of PGE2 on JCS cells, the roles of PGE2 in normal 
haemopoiesis were studied. Colony assay was used to investigate the effect of 
PGE2 on bone marrow cells. Since PGE2 exerts its action through the receptors, the 
expression of PGE2 receptors was examined by reverse transcription-polymerase 
chain reaction (RT-PCR). 
3.1.1 Colony assay 
Bone marrow contains the stem cells, the progenitor cells and the maturing 
cells. Different techniques are used to investigate different category of cells. For 
example, blast-colony-forming cell assays are used in the enumeration of stem cells 
(Metcalf, 1991). Clonal assays are used to monitor progenitor cell levels (Moore 
and Warren, 1987). For the assays of haemopoietic growth factors, the most 
commonly used method is the colony assay (Metcalf, 1970). Most haemopoietic 
growth factors can stimulate the growth of colonies from normal haemopoietic cells, 
and by the study of the number and types of colony formed, one can estimate the 
effect of certain chemical towards haemopoiesis. 
Most often, CSFs are assayed in semi-solid cultures of bone marrow cells. 
With the increasing CSF concentration, colony number increases until a plateau is 
reached, when all available progenitor cells have formed colonies (Metcalf and 
Nicola, 1995). Among the group of CSFs, IL-3 stimulates the proliferation of an 
extremely broad range of haemopoietic cells, which include the blast colonies， 
multipotential colonies, immature megakaryocytic colonies and burst erythroid 
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colonies. In concentrations lowered than 64 ng/ml，IL-3 favors the formation of 
macrophage and doubling such concentration had shifted the lineage preference to 
granulocyte (Metcalf and Nicola, 1995). 
To parallel compare the effect of PGE2 in JCS and bone marrow cells, IL-3 is 
added to bone marrow cell culture. IL-3 is important to prompt the growth of bone 
marrow cells and it is found in WEHI-3B-conditioned medium (Ihle et al., 1982). 
3.1.2 The use of RT-PCR 
Different techniques can be used to analysis mRNA. The most widely used 
method is Northern blotting. The related slot blot and dot blot techniques are semi-
quantitative and these techniques allow the identification of mRNA size and so 
alternatively spliced mRNAs can be detected. Specific labeled probes are used to 
detect electrophoresed filter transferred mRNA, and microgram quantities of 
purified poly(A)+ mRNA is required. These methods are insensitive and time 
consuming since they require the transfer and hybridization for each mRNA, and 
mostly radioactive detection is needed. 
RNase protection assay is a sensitive and semi-quantitative method to detect 
mRNA. Though less amount of poly(A)+ mRNA is required, it requires transfer 
and hybridization for each mRNA and radioactive detection. Another method for 
mRNA analysis is the reverse transcription-polymerase chain reaction (RT-PCR) 
(Rappolee et al., 1988). This method combines the technique of reverse 
transcription (RT) and polymerase chain reaction (PGR) (Saiki et al., 1985). It is 
very sensitive and easy to perform. Data can be obtained within a short time and 
less than 1 ng of total RNA can be used directly as starting material, and the 
poly(A)+ mRNA purification step can be eliminated. The disadvantage of using 
RT-PCR is that the method is not quantitative. 
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RT-PCR can be applied to different areas, including the detection of gene 
transcripts from small amount of RNA, the simultaneous analysis of multiple gene 
transcripts, the detection of mutation in gene transcripts and the cloning of gene 
transcript (Larrick and Siebert, 1995). Many new techniques have been developed 
based on this method. Differential display RT-PCR (DDRT-PCR) (Bauer et al., 
1993) is one of them and it is used to discover the differentially expressed genes. 
Various genes were isolated by DDRT-PCR and diagnostic applications of RT-PCR 
were also found (Larrick and Siebert, 1995). 
The high sensitivity of RT-PCR helps to reveal low abundance gene transcripts. 
It is thus useful to detect the presence of PGE, receptors expressed in JCS and bone 
marrow cells in this experiment. 
3.1.3 Prostaglandin E receptors 
Based on the response to various agonists and antagonists, PGE receptors are 
divided into four subtypes, EPl, EP2, EP3 and EP4. As described previously in 
Chapter One, the receptors each have their own properties and involve in different 
signaling pathways. The cloning of the cDNA of all the subtypes had been done 
and it had also revealed the existence of further heterogeneity. For mouse, the best 
known prostanoid receptor generated is the EP3 receptor, with at least four EP3 
isoforms being found (Narumiya, 1997). In human, EP3 receptor has eight 
different isoforms (Pierce and Regan, 1998) and rat EPl receptor has an addition 
variant form (Okuda-Ashitaka ct al., 1996) 
The heterogeneity of Ihc subtypes is formed through the use of alternative 
splicing. Except for EPl receptor, the mechanism giving rise to other EP isoforms 
involves the use of splice sites located in the cytoplasmic carboxyl termini of the 
receptors (Pierce and Regan, 1998). 
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EPl subtype 
The mouse EPl receptor was cloned and the isolated clone encodes a protein 
consisting of 405 amino acid residues with putative seven-transmembrane domains 
(Watabe et al., 1993). The receptor shows higher affinity to PGE2 than PGEp 
PGE2 induced a rapid increase in intracellular Ca^ ^ concentration in Chinese hamster 
ovary (COS) cells expressing the receptor (Watabe et al., 1993). According to this 
sequence, primer MF557 and MF558 were designed to amplify the transcript of the 
gene. 
EP3 subtype 
EPS is linked to phospholipase C activation via Gi protein, and this activation 
leads to Ca^ ^ mobilization from internal stores and influx from the extracellular 
medium (Irie et al., 1994). At least four types of mouse EPS isoforms were 
reported (Narumiya, 1997). According to the mRNA sequence found in genebank, 
primers were designed to amplify EP3a, (3 and y isoforms. 
The first one being cloned is the EP3a. EP3a consists of 365 amino acid 
residues with putative seven-transmembrane domains. It binds to PGEi and PGE: 
with the same affinity, and PGE2 decreased forskolin-induced cAMP formation in a 
concentration-dependent manner in COS cells expressing the cDNA (Sugimoto et 
al., 1992). Later, EPSP was also being identified, and the two isoforms are only 
different in the sequence of the putative cytoplasmic carboxyl-terminal tail and their 
hybrophobicity. Both isoforms were first considered to exert inhibition of 
forskolin-induced cAMP accumulation (Sugimoto et al., 1993). Later studies 
showed that the two isoforms induced enhancement of adenylate cyclase stimulation 
with different efficiences (Harazono et al” 1994). 
The third isoform found is the 丫 isoform. Similar to a and p isoforms, the y 
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isoform also has a unique amino acid sequence of the putative cytoplasmic carboxy-
teraiinal tail. It is coupled to both stimulation and inhibition of adenylate cyclase 
(Irie et al, 1993). 
EP4 subtype 
The EP4 subtype was first considered to be the EP2 subtype. It consists of 
513 amino acid residues with putative seven-transmembrane domains. The 
receptor possesses long third intracellular loop and carboxyl-teraiinal tail. When 
PGE2 binds to the receptor in COS cells, markedly increased cAMP was observed 
(Honda et al, 1993). Later, a new EP2 was isolated (Katsuyama et al., 1995) and 
the previous one was renamed as EP4. 
In this project, primers were designed to detect the presence of different PGE: 
receptors (EPl，EP4，EP3a, |3 and y) appear in JCS and bone marrow cells, and heart, 
liver and spleen were act as control. 
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3.2 Materials 
3.2.1 Bone marrow cells 
Bone marrow cells were purified from BALB/c mice maintained by the animal 
house in the Chinese University of Hong Kong. 
3.2.2 Cell line 
Frozen stock of 32D cells was kindly given by Dr. K.N. Leung in the 
Department of Biochemistry, the Chinese University of Hong Kong. After thawing, 
32D cells were cultured in RPMI-1640 medium supplemented with 10 % fetal 
bovine serum (FBS, GibcoBRL)，2 mM glutamine, 50 U/ml penicillin, 50 \x\/ml 
streptomycin, and 10 jig/ml neomycin. 1 U/ml of mouse IL-3 was also added to 
the medium, as 32D cells were dependent on the supplement of IL-3 for continue 
growth. 
For JCS cells, they were cultured in RPMI-1640 medium supplemented with 10 
% fetal calf serum (FCS, GibroBRL), 2 mM glutamine, 50 U/ml penicillin，50 |il/ml 
strepomycin, and 10 ^ig/ml neomycin. Both cell lines were incubated under 95 % 
air/5 % CO2 humidified atmospheres at 37 
3.2.3 Chemicals 
1. Acetone Ajax 7 
2 Agar Sigma A9915 
3. Calcium chloride, dihydrate (CaC^HaO) Sigma C3881 
4. Cesium chloride (CsCl) GibcoBRL 15507-015 
5. Citric acid (andydrous) Ajax AR 
6. Diethyl pyrocarbonate (DEPC) Sigma D5758 
7. Ethanol Riedel-deHaen 32221 
8. Ethylenediaminetetraacetic acid (EDTA) Sigma ED2SS 
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9. Fetal bovine serum (FBS) GibcoBRL 16()0()-044 
10. Formaldehyde (37%) Merck 104000.025 
11. Guanidinium thiocyanate (GT) Sigma G9277 
12. Hematoxylin solution, Gill No.3 Sigma GHS-3-16 
13. Hydrochloric acid, 36 % (HCl) Ajax 1364 
14. Lauryl sulphate (SDS) Sigma L5750 
15. p-mercaptoethanol Sigma M7154 
16. Potassium chloride (KCl) Sigma P4504 
17. Potassium phosphate, monobasic (KH2PO4) Sigma P5379 
18. Penicillin-streptomycin-neomycin (PSN) GibcoBRL 15640-055 
19. Prostaglandin E�(PGE^) Sigma P5640 
20. RPMI -1640 medium GibcoBRL23400-021 
21. Sodium acetate (NaOAc) Sigma S2889 
22. Sodium bicarbinate Sigma S5761 
23. Sodium chloride (NaCl) Sigma S9625 
24. Sodium citrate (Trisodium salt) Sigma S4641 
25. Sodium hydroxide (NaOH) Sigma S5881 
26. Sodium phosphate, dibasic (NasHPO*) Sigma S0876 
27. Thiazolyl blue (MTT) Sigma M5655 
28. Tris Pharmacia 17-1321-01 
3.2.4 Primers 
4 sets of primers were designed to amplify the PGE2 receptors from the cDNA 
of JCS cells and bone marrow cells. The information of the primers is listed at the 
following table 3.1. Primers amplifying the gapdh were also used to test the 
efficiency of cDNA. 
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Table 3.1 Primers used in the RT-PCR 
Primer Primer sequence Gene amplified Tm Product 
number size 
MF 557 ~ 5 ' C T G CTG GAG GGG CGT GTC AT 3， EPl receptor 66 686 bp 
MF 558 5，TGG CCG CTG CAG GGA GTT AG 3' 66 
MF 559 5'GGC AGA TCC GAG CGG CAG TA 3， EP4 receptor 6 6 � C 512 bp 
MF 560 5'GGG TCC AGG ATG GGG TTC AC 3' 66 
MF 561 ^ ^ 5 T C G CCT GGC TTC GCT GAA CC 3' EP3a receptor 6 6 � C 412 bp 
MF 562 5'GTC GTC TTG CCC CCG TCT CA 3' EP3p receptor 6 6 � C 323 bp 
MF 565 5'CAA AAG TCT CCT CCC CCA ATA AT 3 ' E P S y receptor 6 6 � C 626 bp 
MF 566 5TGA GAC TCG GGA GAC ITT TAC TT 3' 66 X 
MF 214 5'ACC ACA GTC CAT GCC ATC AC 3， GAPDH 62 °C 452 bp 
MF 215 5，TCC ACC ACC CTG TTG CTG TA 3， 62 °C 
3.2.5 Solutions and buffers 
1. 0.66 % agar 0.264 gm agar dissolved in 40 ml milli-Q 
water. Solution being autoclaved 
2. Cell lysis buffer 10 % SDS in 0.01 N HCl 
3. Cesium chloride solution 5.7 M CsCl，0.01 M EDTA (pH 7.5) 
4. Citrate-Acetone-Formaldehyde solution 25 ml citrate solution together with 64 ml 
acetone and 8 ml 37 % formaldehyde 
5. Citrate solution 18 mM citrate acid (anhydrous), 9 mM 
sodium citrate (trisodium salt), 12 mM NaCl 
6. 5 X First strand buffer (GibcoBRL) 250 mM Tris-HCl pH 8.3，375 mM KCl, 15 
mM MgCl2 
7. Guanidinium thiocyanate solution 4 M guanidinium thiocyanate, 0.1 M Tris-
HCl (pH7.5), 1 % P-mercaptoethanol 
8. Magnesium chloride solution 25 mM MgCl: 
(Promega M1861) 
8. MTT solution 4 mg thiazolyl blue in 1 ml phosphate 
buffered saline. Solution being filtered. 
9. Phosphate buffered saline (PBS) 8 g NaCl, 0.2 g KCl, 1.44 g NaaHPO* and 
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0.24 g KH2PO4 in 1 L H2O, adjust to pH 7.4 
by NaOH 
10. 10 mM Prostaglandin E: 1 mg PGE2 dissolved in 284 [il absolute 
ethanol 
11.10 X Reaction buffer (Promega M1861) 500 mM KCl, 100 mM Tris-HCl (pH 9.0 at 
25 oQ 
12.1 X RPMI-1640 medium 1 package of RPMI powder dissolved in 1 L 
milli-Q water. 2 gm sodium bicarbonate 
was added and the solution was adjusted to 
pH 7.2 by 1 M NaOH. Medium being 
filtered. 
12. 2 X RPMI-1640 medium 1 package of RPMI powder dissolved in 500 
ml milli-Q water. 4 gm sodium 
bicarbonate was added and solution was 
adjusted to pH 7.2 by 1 M NaOH. 
Medium being filtered. 
3.2.6 Enzymes and reagents 
1. 100 mM Dithiothreitol (DTT) Promega P1171 
2. Taq DNA polymerase Promega M1861 
3. M-MLV reverse transcriptase (200 U/\x\) GibcoBRL 28025-013 
4. Mouse IL-3 From Dr. N.K. Mak 
5. Oligo d(T)i2.i8 Pharmacia 27-7858-01 
6. Recombinant RNasin ribonuclease inhibitor (40 U/^il) Promega N2511 
7. Ultrapure dNTP set Pharmacia 27-2035 
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3.3 Methods 
3.3.1 Titration of mouse IL-3 
Mouse IL-3 was a generous gift from Dr. N.K. Mak in the Department of 
Biology, the Hong Kong Baptist University. The unit of mouse IL-3 was measured 
in the MTT assay using a factor-dependent mouse cell line, the 32D cells. 
32D cells were first collected by centrifugation at 1000 rpm for 5 minutes. 
The supernatant was removed and cells were washed in 5 ml 1 X RPMI-1640 
medium. Cells were recollected again and resuspended in 2 ml 1 X RPMI-1640 
medium. After counting the cell number by the use of hemocytometer, 2 x 10^ of 
32D cells were seeded in wells of the 96-well plate. Cells were starved for 3 hours 
so as to enhance the sensitively of the cells. After the starvation, different 
concentrations of mouse IL-3 were added to the wells and the whole plate was 
incubated at 37 for 72 hours. MTT assay was then carried out as described at 
section 2.3.3. One unit of mouse IL-3 was equal to the ED50 measured in the MTT 
assay. 
ED50 = [maximum OD570 of cultured cell-(OD570 of cultured cells+2xSD)]+2 
3.3.2 Determination of suitable IL-3 concentration for growth of bone marrow 
cells in colony assay 
Mouse IL-3 is essential to maintain the survival of bone marrow cells. 
Suitable amount of IL-3 helps the bone marrow cells to form countable colonies in 
the agar. The effect of IL-3 on bone marrow cells differentiation was first 
determined by the colony assay. Total number of colonies formed was counted and 
the types of colony were recorded. Method for colony assay is listed below. 
3.3.2.1 Preparation of bone marrow cells 
BALB/c mice were dissected. Femur bones were taken out and the ends of 
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the bones were cut. 1 ml syringe containing 1 X RPMI-1640 medium was used to 
wash out the bone marrow cells. Cells were then collected by centrifugation at 
1000 rpm for 5 minutes. The supernatant was then removed and the cells were 
further washed with 5 ml 1 X RPMI-1640 medium. Finally，the cells were 
collected and resupended in 3 ml 1 X RPMI-1640 medium. Only white blood cells 
were counted using a hemocytometer (Sigma). Bone marrow cells were kept at 4 
until used. 
3.3.2.2 Preparation of culture medium for colony assay 
Medium cocktail solution containing 40 % heat-inactivated FBS, 2 % PSN, 4 
mM Glutamine and 56 % 2 X RPMI-1640 medium was prepared and kept at 37 °C 
water bath. Same volume of sterilized 0.66 % agar was melted and kept at 42 
The medium cocktail and agar was then mixed together at a ratio of 1:1. Bone 
marrow cells were added to the mixture and mixed thoroughly. On the whole, the 
number of bone marrow cells added to each well was 8 x 0.4 ml of the mixed 
culture was quickly dispensed to each well of the 24 well leukocyte migration plate 
(Corning). The agar cell cultures were allowed to solidify at room temperature for 
about 15 min. 0.5 ml 2 X RPMI-1640 medium containing different amount of 
mouse IL-3 was added to each well. The whole plate was incubated at 37 °C in a 
humidified atmosphere containing 5 % CO: for 7 days. Phosphate buffered saline 
was used to wash the agars out of the wells and the agar discs were transferred to 
clean slides. After drying, the colonies were fixed with citrate-acetone-
formaldehyde solution for 30 seconds, rinsed with running water for 1 minute and 
stained with hematoxylin solution for 2 minutes. A final rinse with running water 
was performed and agar disc was air-dried before mounted with balsam. Colonies 
containing more than 50 cells were counted and the types being distinguished. 
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3.3.3 Investigation of the effect of PGE� on normal haemopoiesis by colony 
assay 
From the above experiment, a final concentration of 50 U/|il mouse IL-3 was 
enough to help the formation of colonies. The effect of PGE? was then investigated. 
Bone marrow cells and culture medium was prepared as stated at section 3.3.2.2. 
Different concentrations of PGE? and 50 U/|il mouse IL-3 were added to each well. 
After incubation at 37 °C in a humidified atmosphere containing 5 % CO2 for 7 days, 
colonies containing agar disc was then dried and stained for colony counting. 
3.3.4 Detection of PGE� receptors expression on JCS cells and bone marrow 
cells 
3.3.4.1 Preparation of cell lysates 
Approximately 2x1 CT JCS cells and bone marrow cells were collected by 
centrifugation at 1000 rpm at 4 for 5 minutes. 2 ml 1 X RPMI-1640 medium 
was used to wash the cells once. Cells were than washed by centrifugation at 1000 
rpm at 4 °C for 5 minutes. The pellet was resuspended in 200 1 X RPMI-1640 
medium. The cells were added dropwise into 4 ml 4 M guanidinium thiocyanate 
solution. The remaining cell lysates were kept at -70 until use. 
3.3.4.2 Preparation of total RNA of JCS cells and bone marrow cells 
Total RNA was prepared using guanidinium thiocyanate/cesium chloride 
ultracentrifugation method as described by Chirgwin at 1979. 4.5 ml cell lysates 
prepared previously were thawed at 65 °C for 5 minutes and then chilled on ice 
quickly. The cell lysates were squeezed through a 19 G syringe for several times. 
They were then loaded carefully on 1 ml 5.7 M CsCl cushions in the polyallomer 
ultracentrifuge tubes (Beckman Cat. No. 270-233833). 
Ultracentrifugation was performed at 32000 rpm with SW60Ti rotor (Beckman) 
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at 18 °C for 18 hours. After ultracentrifugation, supernatant above the RNA pellet 
was removed by aspiration. Without disturbing the pellet, trace amount of 
supernatant remained was discarded by quickly inverting the tube. The inverted 
tube with RNA pellet attached was air dried for 5 minutes. Clean scalpel was used 
to cut off the top portion of the tube. A total of 400 [il 0.1 % DEPC-treated water， 
with aliquots of 40 i^l per time, was used to resuspend the RNA pellet. 
The RNA sample was then transferred to a clean eppendorf and spinned 
quickly at 14000 rpm at 4 for 1 minute. 45 fil 3 M NaOAc and 1 ml 100 % 
ethanol were added and the whole mixture was centrifuged at 14000 rpm at 4 for 
30 minutes. Supernatant was removed carefully and the pellet was washed by 1 ml 
70 % ethanol for once, followed by 1 ml 100 % ethanol for final washing. The 
washed RNA pellet was vacuum dried for 10 minutes and resuspended in 50 0.1 
% DEPC-treated water. The quality and quantity of RNA was assayed by 
spectrophotometric measurement (OD260nm and OD280nm)-
3.3.4.3 RT-PCR 
Reverse transcription 
RNA samples of JCS and bone marrow cells were first heat at 65 for 10 
minutes to denature the secondary structures. The RNA was then quickly chilled 
on ice and kept at 4 until use. Each RT reaction contained 1 \i\ RNase inhibitor 
(40 U/^il), 1 \i\ Oligo dTi2_i8 (0.1 [ig/yd), 1 dNTPs (10 mM), 4 fxl 5 X first strand 
buffer, 2 i^l DTT (100 mM), 1 i^l M-MLV reverse transcriptase (200 U尔 1) and 1 \ig 
RNA. Reaction cocktail was prepared in a 1.5 ml eppendorf and the reaction 
volume was top up to 20 by adding DEPC-treated water. After a gentle mix by 
vortex and a quick spin in centrifuge, the cocktail was incubated at 37 water bath 
and the RNA sample was reverse transcribed for 1 hour. The reaction was then 
terminated at 4 °C and the product was kept at -20 °C until used. 
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Polymerase chain reaction 
The RT product prepared previously was first heat to 94 for 10 minutes for 
denaturation and then quickly chilled on ice for 3 minutes. Each PGR reaction 
contained 5 x^l 10 X reaction buffer, 3 i^l MgCl: (25 mM), 2 \i\ upper primer (25 
pmol/|il), 2 \il lower primer (25 pmol/^il), 1 dNTPs (10 mM), 1 \i\ DNA 
polymerase (0.5 U/jil) and 2 i^l RT product (equal to 0.1 \ig of total RNA). The 
reaction volume was top up to 50 \i\ by adding DEPC-treated water. The reaction 
cocktail was prepared in a thin wall PGR tube and kept at 4 After a gentle mix， 
the PCR tube was placed in the thermal cycler (Perkin-Elmer GeneAmp system 
9600) and PCR was started. 
The PCR profile was started from preincubation hold at 94 for 2 minutes. 
After that, denaturation was done at 94 for 1 minute, annealing of primers at 66 
and elongation at 72 for 1 minute. As to avoid non-specific bands generated 
during the re-amplifying procedure, touchdown PCR was proceeded. Starting from 
the second cycle, annealing temperature was lowered 1 every next cycle for 10 
cycles. The remaining cycles were performed at denaturation at 94 for 1 minute, 
annealing at 56 for 1 minute and elongation at 72 °C for 1 minute. After the 
complete of 30 cycles, a final extension at 72 °C for 10 minutes was done and the 
PCR product was analyzed on a 2 % agarose gel. 
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3.4 Results 
3.4.1 Titration of mouse IL-3 
32D cells were starved and different concentrations of mouse IL-3 stock 
solution were added. After incubated for 3 days, MTT solution was added to each 
well and another 4-hour incubation was carry on. 100 per well of lysis buffer 
was added to release the black precipitate formed inside cells and 005翻 was 
measured. The MTT result is presented at Figure 3.1 
One unit of IL-3 is defined as the ED50 measured in this MTT assay. The 
number of 32D cells present is directly proportional to the degree of ODsyonm. 
Mouse IL-3 was diluted with 1 X RPMI-1640 medium. In Figure 3.1，when 1 jil of 
IL-3 was diluted with 259000 medium, it reached the ED50 of this assay and this 
dilution is defined to contain 1 U of IL-3. The mouse IL-3 stock solution is 
calculated to have a concentration of 130 U/^il. 
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Figure 3.1 Titration of mouse IL-3. 32D cells were used for the mouse IL-3 
assay as described in section 2.3.3. 2 xlO^ were seeded in the wells of 24-well 
plate and starved for 3 hours before adding different amount of mouse IL-3. 32D 
cells alone without mouse IL-3 were set as cell control. After 3 days incubation, 
MTT assay was performed and the OD^^Q^^ is plotted against the dilution of mouse 
IL-3 used in the assay. One unit of mouse IL-3 is equal to the ED50 measured in the 
assay. 
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3.4.2 Effect of mouse IL-3 on normal haemopoiesis 
Different concentration of mouse IL-3 was added to bone marrow cells. 
The number of macrophage colonies, granulocyte colonies and mixed 
granulocyte/macrophage (mixed G/M) colonies was counted. The result is listed in 
Table 3.2. Such colony formation has a characteristic sigmoid dose-response curve 
(Figure 3.2). When 50 U/jil mouse IL-3 per well was added to the culture, there 
was 150 colonies produced in the culture. This concentration of mouse IL-3 is 
used at the later colony assay. Each dilution was prepared for duplicate and the 
result is expressed at means 土SD. 
From Table 3.2，it is noticed that mouse IL-3 can induce the formation of 
macrophage, granulocyte and mixed G/M colonies formation. When the 
concentration of mouse IL-3 increased, the percentage of macrophage colonies 
formed increased also. On the other hand, the percentage of granulocyte and 
mixed G/M colonies decreased. Since the number of colonies formed increased 
with the concentration of mouse IL-3 being added, it is concluded that the test range 
of mouse IL-3 in this experiment favors the formation of macrophage colonies. 
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Table 3.2 Effect of mouse IL-3 on normal haemopoiesis. 
Treatment Concentrations Percentage of colony (mean土SD) 
Macrophage Granulocyte Mixed G/M 
Mouse IL-3 0.78 U/\il 19.7±7.6 33.4±23.5 47 .0±16 .0^ 
1.56 U/jil 14.3±0.0 41.5±2.1 51.5±12.1 
3 . 1 3 \J/[il 1 8 . 1 ± 4 . 3 3 5 . 8土 5 . 9 4 6 . 2 ± 1 . 6 
6.25 U/[i\ 24.4±4.2 24.0±23.9 51.6±28.0 
12.50 U/pil 28.6±14.3 29.3±0.4 42.1±13.9 
25.00 U/^il 39.5±3.0 22.4±0.0 38.2±3.0 
50.00 U/iil 48.6±0.4 23.3±1.6 28.2±1.8 
100.00 U/^il 53.9±0.7 21.4±5.6 24.8±4.9 
200.00 U/^il 50.0±7.1 22.0±5.0 28.2±7.7 
8 xl04 bone marrow cells were cultured with mouse IL-3 for 7 days. Colonies 
were stained with Hematoxylin solution. The number of macrophage, granulocyte 
and mixed G/M colonies were counted. Each dilution was prepared for duplicate 
and the result is expressed at means 土SD. 
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Figure 3.2 Effect of mouse IL-3 on the number of colony formed by bone marrow 
cells. 8 xlO^ bone marrow cells were cultured with mouse IL-3 for 7 days. 
Colonies were stained with Hematoxylin solution. The number of colony formed 
is plotted against the concentration of IL-3 used. 
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3.4.3 Effect of PGE2 on mouse IL-3 driven normal bone marrow cell 
differentiation 
The effect of PGE? on normal haemopoiesis was studied by colony assay. 
Different concentrations of PGE2 (1.56 i^M to 25 ^iM) were added to the bone 
marrow cells supplemented with 50 U/fxl of mouse IL-3. The cells were cultured 
for 7 days and colonies were formed within the agar. The number of macrophage 
colonies, granulocyte colonies and mixed granulocyte/macrophage (mixed G/M) 
colonies were counted. Each concentration was prepared for triplicate and the 
results are expressed at means ±SD and are listed in Table 3.3. It is noticed that 25 
\iM PGE2 drastically increases the granulocyte colonies up to 71 % and suppresses 
the macrophage colony formation down to 4 %. Ethanol, the solvent for PGE〗， 
does not demonstrate the same effect. 
The total number of colonies formed was also counted and the result is showed 
in Figure 3.3. It is found that PGE2 inhibits colony formation. When higher 
concentration of PGE2 was used, the number of colonies formed decreased. It is 
thus concluded that PGEj can suppress the formation of macrophage colonies in the 
highest extent among the three types of colony being counted. 
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Table 3.3 Effect of PGE2 on mouse IL-3 driven normal bone marrow cells 
differentiation. 
Treatment Concentrations Percentage of colony (mean±SD) 
Macrophage Granulocyte Mixed G/M 
Medium control - 42.1±3.5 24.5±7.7 33.4±4.8 
Ethanol control 0.016 % 44.5±2.8 20.5±3.3 35.0±5.7 
0.031 % 46.3±5.3 18.3±4.9 35.4±8.1 
0.063 % 45.5±5.3 20.8±2.5 33.7±3.4 
0 . 1 2 5 % 50.0±2.5 1 7 . 9 ± 6 . 7 3 2 . 2 ± 6 . 7 
0.250 % 46.5±6.0 22.9±2.7 30.6±4.2 
PGE2 1 .56 ^iM 2 2 . 8 ± 3 . 8 4 7 . 5 ± 4 . 4 2 9 . 7 ± 4 . 0 
3.13 _ 21.9±2.3 53.4±8.8 24.7±8.4 
6.25 [iM 16.3±5.1 65.4±3.8 18.4±2.1 
12.50 \iM 8.7±7.4 71.2±5.0 20.1±3.1 
25.00 \iM 4.0±6.9 71.5±17.7 24.5±16.5 
Different concentrations of PGE2 were tested with their effect on normal 
haemopoiesis by colony assay as described at method 3.3.2.2. 8 xlO"^  bone marrow 
cells were seeded in wells of 24-well plate and cultured with PGE2 plus mouse IL-3 
for 7 days. Colonies were harvest and stained with Hematoxylin solution. The 
number of macrophage, granulocyte and mixed G/M colonies were counted. Each 
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Figure 3.3 Effect of PGE: on bone marrow cells. 8 x 10^ bone marrow cells were 
incubated with various concentrations of PGE2 and mouse IL-3 (50 U/fxl) for 7 days. 
The effect was tested by colony assay as described at method 3.3.2.2. For ethanol 
control and cell control, the cultures were also supplemented with 50 U/jil mouse 
IL-3. Colonies were stained with Hematoxylin solution. The number of colony 
formed is plotted against the concentration of PGE2 used. 
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3.4.4 Analysis of total RNA prepared from uninduced JCS cells and bone 
marrow cells 
Total RNA of JCS cells and bone marrow cells was purified by guanidinium 
thiocyanate/cesium chloride ultracentrifugation. The quality and quantity of RNA 
were assayed by spectrophotometric measurement (OD260nm and ODasonm) 
(Biophotometer，Eppendorf). The purity of the RNA samples is estimated by the 
ratio of OD260nm to OD280nm- The results are showed in Table 3.4. 
Heart, liver and spleen are the organs closely related to haemopoiesis. Most 
of the genes are expressed in these organs and so their RNA was also used to act as 
positive controls. Total RNA of mouse heart, liver and spleen were kindly 
prepared by Mr. Y.B. Chan. Parallel RT-PCR was set for the five samples: RNA 
from heart, liver, spleen, JCS and bone marrow cells. It was done to ensure the 
efficiency of the primers and the polymerase chain reaction. 
The five RNA samples were tested on agarose gel for degradation and possible 
contamination with residual genomic DNA. 1 \ig of total RNA from each sample 
was separated on 1 % agarose gel (Figure 3.4). From the gel photo, 28S and 18S 
ribosomal RNA appeared as sharp bands, indicating that no major degradation of 
RNA has occurred. Moreover, there is no significant genomic DNA contamination 
found in the samples. 
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Table 3.4 Spectrophotometric analysis of total RNA prepared from JCS and bone 
marrow cells 
Sample O'^ ieonJO'^ isonm Concentration 
Uninduced cells 1.45 1.5261 \ig/\il 
Bone marrow cells 1.48 1.6089 \ig/\il 
^ ^ ^ ^ H ^ ^ R H f ^ n r ^ l 28S 
^ ^ ^ M i i i y i i i y M M i ‘ � m “ i • i 
Figure 3.4 Gel electrophoresis of RNA samples. 1 |ig of each RNA samples was 
added with 9 DEPC-treated water. The RNA samples and the marker were 
loaded onto the 1 % agarose gel. Gel was run for 45 minutes at 80 V. RNA was 
visualized and the relative intensities of 28S and 18S rRNA bands were checked. 
Lane M is the 1 kb plus DNA ladder marker. JO represents RNA sample of JCS 
cells and BM for bone marrow cells sample. H，L and S represent RNA sample of 
heart, liver and spleen respectively. 
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3.4.5 Expression of gapdh in heart，liver, spleen, JCS and bone marrow cells 
Total RNA of mouse heart, liver, spleen, JCS and bone marrow cells were first 
reverse transcribed into cDNA. As to confirm the success of the transcription 
process, housekeeping gene gapdh was first amplified from the RT products through 
the polymerase chain reaction. The PCR products were analyzed by gel 
electrophoresis. 5 (il PCR product of each sample was resolved in 2 % agarose gel 
(Figure 3.5). From the figure, bands of the desired size are amplified and clearly 
seen, which indicates the success of reverse transcription and the RT products are in 
good condition to be used. 
M JO BM H L S 
Fig 3.5 Gel electrophoresis of PCR products from amplification of gapdh in heart, 
liver, spleen, JCS and bone marrow cells. RNA samples was first reverse 
transcribed as described in method 3.3.4.3. 2 jil of each RT product was used for 
PCR reaction. PCR profile was same as described in method 3.3.4.3 and 30 cycle 
reactions were performed. 5 \il of PCR product for each sample and the marker 
were loaded onto 2 % agarose gel and gel electrophoresis was performed. Lane M 
is the 1 kb plus DNA ladder marker. JO represents PCR products from JCS cells 
and BM for bone marrow cells. H，L and S represent PCR products from heart, 
liver and spleen respectively. 
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3.4.6 Expression of PGE! receptors in heart, liver, spleen, JCS and bone 
marrow cells 
After checking the efficiency of cDNAs of the five samples, the same set of RT 
products of each sample were used to amplified different PGE] receptors. 
Expression of the five types of PGE2 receptors, namely epl, ep3a, ep3y and 
ep4 were tested. The result is showed in Figure 3.6. 
The expected size of amplified fragment for epl was 686 bp. As shows in the 
gel photo, the band is amplified in RT product of heart, liver and spleen but not in 
JCS and bone marrow cells. The expected size of amplified fragments for ep3a 
and ep3^ are 412 bp and 323 bp respectively. The gel photo shows that except JO, 
all other samples can amplify the two bands. All the five samples can amplified 
the fragment for ep3y, which is expected to be 626 bp. For amplification of ep4, it 
is expected to be of size 512 bp and none of the sample shows the amplified 
fragment. Details of the result will be discussed in section 3.5.2. 
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Figure 3.6 Expression of PGE� receptors (EPl, EP4, EP3a，p and y) in heart，liver, 
spleen, JCS and bone marrow cells. 2 jil of each RT product was used for PCR 
reaction. PCR profile was same as described in method 3.3.4.3 and 30 cycle 
reactions were performed. The whole set of RT-PCR was repeated for twice. 5 
of PCR product for each sample and the marker were loaded onto 2 % agarose gel 
and gel electrophoresis was performed. Lane M is the 1 kb plus DNA ladder 
marker. JO represents PCR products from JCS cells and BM for bone marrow cells. 
H, L and S represent PCR products from heart, liver and spleen respectively. 
83 
3.5 Discussion 
3.5.1 Effect of PGE2 on IL-3 driven normal bone marrow cells differentiation 
When different concentrations of PGE2 ranged from 1.56 [iM to 25 i^M were 
added to the bone marrow cells supplemented with mouse IL-3, cell colonies were 
formed. From Table 3.3, it shows that the higher the concentration of PGE2 was 
use, the higher the percentage of granulocyte colonies being formed. For the 
control group, it shows that solely IL-3 or the combination of IL-3 and ethanol (the 
ethanol control) slightly favors the bone marrow cells to differentiate into 
macrophage. This may indicate that PGE2 can counteract the effect of IL-3 in 
driving the bone marrow cells to differentiate into granulocytic lineage. 
From the result, PGE? seems to favor the formation of granulocyte (Table 3.3). 
However, this result may be due to its suppression of macrophage formation. In 
human haemopoiesis, PGE: markedly reduces M-CSF synthesis by bone marrow 
stromal cells (Bess et al., 1999). Through the action of EP2/EP4 receptor, PGE: 
regulates the secretion of M-CSF by an increase of intracellular cAMP levels in 
bone stromal marrow cells. It may be possible that PGE2 also reduces M-CSF 
synthesis by bone marrow cells and so reduce the number of macrophage colonies 
formed. 
Actually, when consider the effect of PGE? on the number of colonies formed 
(Figure 3.3), it was found that PGE2 inhibited colony formation. When higher 
concentration of PGE2 was used in the test, the number of colonies being found 
decreased. It is thus concluded that PGE2 can suppress the formation of 
macrophage colonies in the highest extent among the three types of colony being 
counted. Our result thus matches with Bess' founding. 
Interestingly, the effect of PGE2 towards normal bone marrow cells and JCS 
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cells is totally different. From the result of 2.4.4 (Table 2.2), it shows the effect of 
PGE2 on JCS differentiation. Different concentration of PGE2 was used to induce 
JCS cells and the number of macrophage found increased with the concentration of 
PGE2 used. 25 \iM of PGE: induced 74 % of JCS cells to differentiate into 
macrophage. However, same concentration of PGE2, when compared with the 
ethanol control, suppressed macrophage colony formation from 46.5 % to 4 % 
(Table 3.3). Since PGE2 exerts its effect through the receptors, it was questioned 
whether there were different expression of PGE2 receptors at JCS and bone marrow 
cells. 
3.5.2 Expression of PGE! receptors in heart, liver, spleen, JCS and bone 
marrow cells 
EPl subtype 
RNA of mouse heart, liver and spleen can amplify the expected band which is 
of 686 bp. A sharp band of size larger than Ikb is also amplified among the five 
samples. After further investigating the mouse EPl gene, it is found that the gene 
is totally overlapped with another gene, the PKN gene. PKN is a newly discovered 
protein kinase that has been shown to mediate GTPase Rho dependent intracellular 
signaling, and it is situated at the mouse epl prostanoid receptor gene locus and that 
the two genes are overlapping in a tail-to-tail manner (Batshake and Sundelin, 1996). 
The gene organisation of the two genes is illustrated at Figure 3.7. 
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Fig 3.7 Gene organization at the mouse epl/pkn locus and transcripts produced. 
The central line represents the 7.2 kb of sequenced genomic DNA (deposited in the 
database). Open boxes represent exons. Above the line are the seven last exons 
of the pkn gene, denoted by letters t to z. The epl exons are numbered I to III and 
are shown under the line. “ ATG" and “ TGA" are the start and stop codons of the 
epl gene, while “ TAG" indicates the pkn stop codon. The 3'-ends of the two 
identified pkn transcripts (short and long) is shown in the last pkn exon. Solid bars 
illustrate the three mRNAs produced from this locus. (Figure adopted from 
Batshake and Sundelin, 1996) 
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Primer MF 557 and 558 were designed to amplify the sequence within the exon 
II and exon III of the epl. As shows in Figure 3.7, the same pair of primer can also 
amplify the long transcript of the pkn. From the gene sequence, if pkn transcript is 
amplified, the band will has the size of 1105 bp, and this size matches with the band 
shown in the photo (Figure 3.6). From our result, epl is expressed in heart, liver 
and spleen tissues, but not in JCS and bone marrow cells. Interestingly, bone 
marrow cells also express a low level of pkn long mRNA. 
EP 3 subtype 
As shows in Figure 3.6, the expression level of ep3y mRNA in bone marrow 
cells is higher than in JCS cells. ep3a and (3 are expressed in bone marrow cells 
but not in JCS cells. Since the three isoforms are couple to different G protein 
(refer to 1.3.3)，they may give different G protein-linked signaling to the cell. 
EP4 subtype 
In Figure 3.6，no sample shows the expected band. It cannot be concluded 
that there is no expression of ep4 as no positive control was provided. The primer 
pair may not be suitable to amplify the transcript and so new primers should be 
designed to redo the experiment. 
As a conclusion, both JCS and bone marrow cells show the expression of ep3y, 
moreover，the two samples have no expression of epl. The difference among the 
two in this experiment is the expression of ep3a and (3. Bone marrow cells have 
the expression of the two isoforms whereas JCS cells have not. As bone marrow 
cells show an opposite response towards PGE2 induction, one of the causes maybe 
due to the different expression of EPS isoforms. The difference in expression of 
EPS isoforms may also turn on different gene regulatory system. 
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Chapter Four Gene expression profile of JCS cells under 5 hours 
Prostaglandin E2 induction 
4.1 Introduction 
When cells or tissues are being stimulated, they will give their response by 
regulating the expression level of different genes, followed by the alteration of 
protein levels that brings morphological or physiology changes. The problem we 
need to tackle is to find out the mechanism of gene regulation and the function of the 
gene in a particular cellular process. Knowing how the gene expression changed 
by the stimuli and the gene-gene interactions may help us to understand more about 
the effect of the stimuli. 
Protein is the ultimate product of a gene. The measures of protein level reflect 
the exact role of the corresponding gene. But till now, direct measurement of 
protein level is expensive and it is hard to be done in a high-throughput way. The 
measures of gene transcript abundance, on the other way round, may be a 
convenient way to detect the response of a gene towards stimuli. Nowadays, 
different methods are well developed for finding the differential gene expression by 
measurement of mRNA level. 
4.1.1 Review of methods studying differential gene expression 
Differential display is one of the commonly used methods in the detection of 
differentially expressed mRNA. In this method, poly(A)+ mRNA from two 
samples undergoes comparison are isolated. One of twelve possible 
oligonucleotides of sequence T(11)XY [eg. T(11)GC] is used to prime to the mRNA 
for reverse transcription. By the use of a random lO-mer and the oligonucleotide 
T(11)XY used for the previous reverse transcription, the reverse transcribed DNA is 
amplified in a labeled PCR and only the small fraction of DNA molecules to which 
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the random lO-mer anneals will be amplified. PCR products are then separated 
using high-resolution poly aery lamide gel electrophesis. Differentially expressed 
genes are visualized in the gel and is readily cloned by excising the bands, re-
amplifying it using PCR reaction, ligating the band to the vector and then 
transforming the vector into bacteria (Gibson and Somerville, 1993) 
Differential display (Liang and Pardee, 1992) is a rapid method and is easy to 
perform. By the use of PCR reaction, identification of differentially expressed 
genes of low abundance is made possible. Besides, only a small amount of mRNA 
is required to perform the experiment and many samples can also be analyzed on a 
single gel. The problem in using this method is that false-positive results may be 
generated during the PCR reaction, or in the process of cloning the differentially 
expressed PCR products. The number of gene being compared is also limited 
(Carulli et al., 1998). 
A similar method is the RNA arbitrarily primed PCR (RAP-PCR). In this 
method, synthesis of first-strand cDNA is initiated from an arbitrary primer at those 
sites in the RNA that best match the primer. Second-strand synthesis is achieved 
by arbitrary priming using a thermostable DNA polymerase, at sites where the 
primer finds the best matches. These two steps result in a collection of molecules 
that are flanked at their 3' and 5' ends by the exact sequence of the arbitrary primer. 
These molecules serve as templates for high stringency PCR amplification, resulting 
in fingerprint similar in appearance to those generated from genomic DNA 
(McClelland and Welsh, 1994). Similar to differential display, RAP-PCR is mainly 
based on the PCR reaction and it can also compare different samples simultaneously. 
Representational difference analysis (RDA) was first used as a method for 
finding differences between complex genomes (Lisitsyn et al., 1993). The 
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applications of RDA include the cloning of probes for the detection of genetic 
lesions in cancer, the identification of sequences from the genomes of unknown 
pathogens and the rapid isolation of polymorphic markers linked to a trait without 
the use of pre-existing genetic maps (Lisitsyn, 1995). Reverse transcription 
representational difference analysis (RT-RDA) is a derived subtractive cloning 
method that is used to find the differences between two sets of mRNA. 
In RT-RDA, double-stranded cDNA is created from two samples. Linkers are 
ligated to the ends of the cDNA fragments and the cDNA pools are then amplified 
by PCR. The cDNA pool from which unique clones are desired is designated the 
tester and the one which used to subtract away shared sequence is designated the 
driver. After initial PCR amplification, linkers are removed from both cDNA pools 
and unique linkers are ligated to the tester sample. The tester is then hybridized to 
a vast excess of driver cDNA, and sequences that are unique to the tester cDNA pool 
are amplified by PCR. This method is simple and required only small amount of 
starting material (Carulli et al., 1998). But for practical use, it is technically 
challenging and there is undesirable effect of obscuring significant difference in 
gene expression that does not fall into ‘all or nothing' category. Besides, it can 
only make pairwise comparisons (McClelland and Welsh, 1994). 
Expressed sequence tag (EST) sequencing is a method that strongly depends on 
the technique of automated sequencing. The basic idea of this method is that 
cDNA libraries from the samples are first created. Single sequencing reaction is 
performed to each randomly picked clones and each sequencing reaction can 
generate several hundreds base pairs that represents a sequence tag for a particular 
transcript. The sequenced clones need to pass through several sequencing analysis 
steps and then the database of the tested samples is formed. The number of clones 
being sequenced is proportional to the statistical significance of the data and the 
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number of the new genes identified. It can be said that the more sequencing and 
analysis being made, the more information can be got in the experiment. 
Serial analysis of gene expression (SAGE) is another technique that is based on 
sequencing. In this method, a unique sequence tag of 13 or more bases is 
generated for each transcript in the sample. Double stranded cDNA is digested 
with restriction enzyme having a four-base recognition site and then ligated to 
linkers and the whole pool is under amplification. The linkers encode a recognition 
site for a type II restriction enzyme that digests DNA at site 20 nucleotides away 
from the recognition site. The generated sequence tags are then ligated in a defined 
series of steps and the sum of all these steps is a library of clones where each clone 
includes short, unique tags for 20 or more genes. Sequencing of the SAGE library 
is then performed. Relative abundance of each gene is determined by counting or 
clustering the sequencing tags (Carulli et al., 1998). By using this method, high 
throughput can be achieved and different SAGE tag data from different samples can 
be compared. The disadvantage of SAGE is that it is challenging to construct a 
SAGE library with good quality. The data obtained also need to be analyzed 
thoroughly. 
A developing technique that is in use is the DNA chip or microarray 
technology. Its concept is similar to Northern and Southern blots. Since there is 
an increase availability of cDNAs or ESTs, generation of high-density DNA arrays 
is made possible. Microarray relies on the hybridization of a ‘probe，to multiple 
defined cDNAs or EST that have designed spots on a solid phase chip. The probe 
is usually a complex mixture of cDNA fragments generated from mRNA (Kurian et 
al, 1999). The probe may be fluorescence-labeled fragments that bind to the 
corresponding spots and the intensity of emission detected by an argon-ion laser or 
CCD camera. The expression level of each gene is represented by the intensity of 
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hybridization signal. Nowadays, commercial cDNA microarray is available. One 
can also generate his own microarray by purchasing a machine known as the arrayer， 
which robotically spots cDNAs or ESTs onto a glass slide. As fluorescence 
labeling is generally used, a machine known as a reader that consists of 
computerized-inverted scanning fluorescence confocal microscope with a triple laser 
illumination system is also needed. 
The cost for using microarray is comparatively higher. It is a convenient 
method to obtain mass data within a short time. This method is similar to the 
traditional differential screening method (St. John and Davis, 1979) and a large 
amount of RNA is required for making the probe. As the cDNAs or ESTs dotted 
on the slides is of known sequence, there is no need to clone the desire gene. 
However, it is also impossible to discover known gene. 
4.1.2 The choice of method studying differential gene expression 
From the above, each method has its own pros and cons. Differential display, 
RAP-PCR, RT-RDA, EST sequencing and SAGE all can be used to cloned novel 
differentially expressed genes. When new cDNAs or EST is used to dot on the 
slides, microarray can also be used to meet this purpose. For RNA requirement, 
differential display, RAP-PCR and RT-RDA use minute starting materials whereas 
EST sequencing, SAGE and microarray use a larger amount of RNA. When 
compare more than two samples, differential display and RAP-PCR are 
recommended. 
To determine which method to use, the most important thing is to consider the 
aim of the project and the kind of question being addressed. In this project, PGE2 
is used to induce JCS cells. Preliminary data show that PGE2 does have the 
potential to induce monocytic differentiation of JCS cells. Since JCS cells can be 
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induced to differentiate into macrophages and granulocytes, we hope to find out 
what genes are responsible for the lineage preference, and the signal transduction 
pathway of PGE? in JCS cells. Some of the oncogenes are known to participate in 
cell differentiation, we wish to find out their role in the regulation of JCS cell 
differentiation. As cell differentiation and proliferation may also involve cell 
regulators, receptors and a wide broad of genes, the detection of such gene 
expression is also important. The aim of this part of experiment is thus to explore 
the differential expression of known genes, but not the discovery of novel genes. 
Microarray technique seems to best fit with this purpose. 
4.1.3 The microarray 
As mentioned before, microarray is a glass slide onto which single-stranded 
DNA molecules are attached at fixed locations. When comparing two samples, 
RNA are extracted and labeled with two different fluorescent labels. For example, 
the control population may be labeled with a green fluorescent dye while the tested 
sample is labeled with a red fluorescent dye. The probes are washed over the 
microarray and they may hybridize to the corresponding sequences on the slide. 
Relative abundance of hybridized RNA is excited by a laser, and relative expression 
levels of the genes in the sample and the control population can be estimated form 
the fluorescence intensities and the colors for each spot (Brazma and Vilo, 2000). 
The use of fluorescent label is common, but it needs to have relevant equipment 
backups. The minimum requirement is the laser and the computerized microscope. 
It is impossible to determine the fluorescence intensities by other device and the data 
generated also need to be analyzed by computer. An arrayer and the generation of 
cDNAs or ESTs also take time. If the laboratory is planing to investigate the 
method of microarray and maximize its use, it is good to buy all the devices. Due 
to the limitations of equipment for microarray analysis at the moments of 
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performing these experiments, we choose to use radioactive labeling and the 
commercially available micro array filters. Radioactive labeling method is used in 
many areas and it is possible to determine the hybridization signal with the use of 
computer software. Besides, the signal is easier to be normalized and the two 
different probes are hybridized to different identical array. Though it is also time 
consuming in data analysis, it saves cost in a large extent and the results are 
satisfactory. In this experiment, microarray of mouse known genes were 
hybridized with radioactively labeled probes to analysis the PGEj regulated genes in 
the JCS cells. 
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4.2 Materials 
4.2.1 Cell line 
The subclone WEHI 3B (JCS) myeloid leukemia cells (Mak et al., 1993) was 
obtained from Dr. N.K Mak and maintained in this laboratory. The cell line was 
grown in RPMI-1640 medium supplemented with 10 % heat-inactivated fetal bovine 
serum (FBS, GibcoBRL)，2 mM glutamine，50 U/ml penicillin, 50 |LI1 /ml 
streptomycin, and 10 ^ig/ml neomycin. Cells were incubated at 37 °C in a 5 % CO2 
atmosphere. 
4.2.2 Kits 
1. A t l a s ™ Mouse cDNA Expression Array Clontech 7741-1 
4.2.3 Chemicals 
1. Calcium chloride, dihydrate (CaClz.ZHzO) Sigma C3881 
2. Cesium chloride GibcoBRL 15507-015 
3. Diethyl pyrocarbonate (DEPC) Sigma D5758 
4. Ethanol Riedel-deHaen 32221 
5. Ethylenediaminetetraacetic acid (EDTA) Sigma ED2SS 
6. Guanidinium thiocyanate Sigma G9277 
7. Hydrochloric acid, 36 % (HCl) Ajax 1364 
8. Lauryl sulphate (SDS) Sigma L5750 
9. (3-mercaptoethanol Sigma M7154 
10. Potassium chloride (KCl) Sigma P4504 
11. Potassium phosphate，monobasic (KH2PO4) Sigma P5379 
12. Prostaglandin E, (PGE,) Sigma P5640 
13. RPMI-1640 medium GibcoBRL 23400-021 
14. Sodium acetate (NaOAc) Sigma S2889 
15. Sodium bicarbinate Sigma S5761 
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16. Sodium chloride (NaCl) Sigma S9625 
17. Sodium citrate, trisodium salt (NasCitrate. 2H2O) Sigma S4641 
18. Sodium hydroxide (NaOH) Sigma S5881 
19. Sodium phosphate, dibasic (Na^HPOA) Sigma S0876 
20. Sodium phosphate, monobasic (NaHzPCM. H2O) Sigma S0751 
21. Tris Pharmacia 17-1321-01 
4.2.4 Solutions and buffers 
1. Cesium chloride solution 5.7 M cesium chloride, 0.01 M EDTA (pH 
7.5) 
2. 10 X Denaturing solution 1 M NaOH, 10 mM EDTA 
3. Equilibration buffer 10 mM Tris-HCl, pH 7.5 containing 1 mM 
EDTA 
4. Hybridization solution 0.1 mg/ml sheared salmon sperm DNA in 
ExpressHyb™ Hybridization Solution 
5. Guanidinium thiocyanate solution 4 M guanidinium thiocyanate, 0.1 M Tris-
HCl (pH 7.5)，1 % p-mercaptoethanol 
6. 2 X neutralizing solution 1 M NaHzPOd 
7. Phosphate buffered saline 8 g NaCl, 0.2 g KCl, 1.44 g NazHPO* and 
0.24 g KH2PO4 in 1 L H^O, adjust to pH 
7.4 by NaOH 
8. 100 mM Prostaglandin E^ 10 mg PGE! in 284 pil absolute ethanol 
9. 20 % Lauryl sulphate (SDS) 200 g SDS in 1 L 即 
10. 5 X Reaction buffer (Clontech) 250 mM Tris-HCl (pH 8.3), 375 mM KCl, 
15 mM MgCl^ 
11. 20 X Standard saline citrate (SSC) 3 M sodium chloride, 0.3 sodium citrate 
12. 10 X Termination mix (Clontech) 0.1 M EDTA (pH 8.0), 1 mg/ml glycogen 
13. Wash solution 1 2 X SSC, 1 % SDS 
14. Wash solution 2 0.1 X SSC, 0.5 % SDS 
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4.2.5 Reagents 
10 X dNTP Mix (5 mM each dCTP, dGTP, dTTP)include in Clontech 7741-1 
10 X CDS Primer Mix include in Clontech 7741-1 
MMLV Reverse Transcriptase include in Clontech 7741-1 
Dithiothreitol (100 mM) include in Clontech 7741-1 
Control Poly (A) + RNA (0.5 \ig/\il) include in Clontech 7741-1 
Cot-1 DNA (1 mg/ml) include in Clontech 7741-1 
[CX-32P] dATP (10 \iCi/ii\; 3,000 Ci/mmol) Amersham PB10204 
Express ™ Hyb hybridization solution Clontech 8015-1 
Salmon sperm DNA solution GibcoBRL 15632-011 
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4.3 Methods 
4.3.1 Preparation of total RNA from PGE! induced JCS cells 
Approximately 2x10^ cells of the uninduced or PGE: (25 ^iM) induced JCS 
cells were collected by centrifugation at 1000 rpm at 4 for 5 minutes. 2 ml 1 X 
RPMI-1640 medium was used to wash the cells for once. Cells were then 
recollected by centrifugation at 1000 rpm at 4 � C for 5 minutes. They were 
resuspended in 200 \illX RPMI-1640 medium and then were added dropwise into 
4 ml 4 M guanidinium thiocyanate solution. The remaining cell lysates were kept 
at -70 until use. 
Total RNA of the cells was prepared by guanidinium thiocyanate/cesium 
chloride ultracentrifugation method as described in section 3.3.4.2. The quality 
and quantity of RNA were assayed by spectrophotometric measurement (OD260nm 
and OD^sonJ. 
4.3.2 Preparation of cDNA probes 
4.3.2.1 Probe synthesis from total RNA 
The preparation of cDNA probes and hybridization procedures were followed 
to the A t l a s ™ cDNA Expression Arrays user manual (Clontech Cat. 7741-1, 
Protocol no.PT3140-l and 4). 
Probe mixtures were synthesized by reverse transcribing 5 \xg of each RNA 
population using the cDNA Synthesis (CDS) Primer Mix included in the kit and [a-
32p]dATR A reaction cocktail including 8 i^l 5 X reaction buffer, 4 pil 10 X dNTPs 
mix (5 mM each dCTP, dGTP, dTTP), 14 i^l [a-^^P]dATP (10 i^Ci/ptl; 3,000 
Ci/mmol)，2 DTT (lOOmM) and 4 fxl MMLV was first prepared in an eppendorf 
and kept at 4 � C until use. 5 \ig of RNA sample was added together with 1 pil of 
10 X CDS Primer Mix in a new PGR tube. DEPC-treated water was used to top up 
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the reaction volume in PGR tube to 3 \il A parallel labeling reaction with 1 \xl 
control Poly (A)+ RNA was also performed in another PGR tube. 
After mixed well by pipetting and short spinning, the PGR tube was incubated 
in a 70 water bath for 2 minutes. It was then further incubated in a 48 water 
bath for 4 minutes. During the last 2 minutes of 48 incubation, the reaction 
cocktail in the eppendorf tube was put in the 48 water bath as well. When the 4-
minutes incubation was finished, 8 i^l of prewarmed reaction cocktail was added to 
the PGR tube and continued incubating at 4 8 � C for 25 minutes. 1 10 X 
Termination mix was added to stop the reaction. 
4.3.2.2 Column chromatography 
The labeled cDNA was purified from unincorporated ^^P-labeled nucleotides 
and small (<0.1 kb) cDNA fragments by using NICK™ Column (Pharmacia, Cat. 
52-2076-00). Original buffer in the column was discarded. The column was 
supported over a suitable receptacle and then equilibrated with 4 ml of the 
equilibration buffer. After the equilibration buffer had completely entered the gel 
bed, probe mixture was added carefully. 400 jil equilibration buffer was loaded 
into the gel bed. Finally the purified probe was eluted with another 400 jil 
equilibration buffer. 
4.3.3 Hybridizing cDNA probes to the Atlas Array 
The Atlas Array was first prepared by placing in 200 ml heated 0.5 % SDS. 
After a two-minute incubation, the two membranes were transferred to two different 
labeled hybridization bottles. In each bottle, the membrane was rinsed with 
deionized water and prehybridized with 5 ml ExpressHyb buffer containing 0.5 mg 
heat-denatured salmon sperm DNA at 71 °C for 30 minutes. 
Labeled probe of uninduced or PGE: induced cell sample was mixed with 44 
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10 X Denaturing solution and incubated at 71 for 20 minutes. 5 jil of Qt- l 
DNA and 447 |il 2 X Neutralization solution were then added to the probe mixture 
and incubated for another 10 minutes. Being careful not to pour the concentrated 
probe directly on the surface of the membrane, the probe mixture was added to the 
prehybridization solution. Overnight hybridization was carried out and all regions 
of the membrane were in contact with the hybridization solution at all times. 
After hybridization, the membrane was washed with Wash solution 1 at 71 °C 
for 4 times, each last for 30 minutes. Then the membrane was washed with Wash 
solution 2 at 71 °C once. Finally, the membrane was washed in 2 X SSC at room 
temperature for 5 minutes. The membranes were then wrapped in plastic wraps 
and exposed to Kodak BioMax MR film at -70 °C in X-Omatic cassitte (Kodak) for 
72 hours. The X-ray film was developed by the use of KODAK M35 X-OMAT 
Processor. Hybridization signals were analyzed by computer program Lumi 
Analyst 3.1 (Roche) in the Lumi-Imager. 
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4.4 Results 
4.4.1 Spectrophotometric analysis of total RNA after ethanol precipitation 
Since the concentration of the total RNA required in the cDNA labeling 
reaction was about 5 total RNA samples of the uninduce or induced JCS cells 
(refer to section 3.4.4) were concentrated by ethanol precipitation. Again, the 
quality and quantity of RNA were assayed by spectrophotometric measurement 
(OD260nm and ODagonm). Thc purity of the RNA sample was estimated by measuring 
the ratio of OD260nm to OD28�nm. The result was showed in Table 4.1. 
Table 4.1 Spectrophotometric analysis of total RNA prepared from PGE? induced 
JCS cells after ethanol precipitation. 
Sample O^ieonJO^isonm Concentration 
Uninduced cells 1.55 5.0772 [ig/yd 
JCS cells of 5 hours PGE? induction 1.56 3.5123 i^g/^ il 
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4.4.2 Hybridization of cDNA probes to Atlas Array 
The Atlas™ Mouse cDNA Expression Array (Clontech) includes 588 mouse 
cDNAs spotted on positively charged nylon membranes. Each dot included 10 ng 
of cDNA and was arrayed in duplicate. Plasmid and bacteriophage DNA were 
included as negative controls to confirm hybridization specificity, along with several 
housekeeping cDNAs as positive controls for normalizing mRNA abundance. The 
gene orientation of this Atlas Array was roughly presented (Figure 4.1). 
Two identical Atlas Arrays were used in this experiment. Radioactivity 
labeled cDNA probes synthesized from uninduced and PGE2 induced JCS cells were 
hybridized to each of the Atlas Array membrane respectively. The hybridization 
signals were detected by autoradiograph (Figure 4.2) and quantified by using 
computer program Lumi Analyst 3.1 (Roche) in the Lumi-Imager (Table 4.2，table 
4.3 and table 4.4). 
Fold of change of the hybridization signals among the two samples was 
calculated by dividing the hybridization signals of the PGE2 induced cells with that 
of the uninduced cells (Table 4.5). Genes with obvious regulation were listed out 
(Table 4.6). 17 genes were upregulated or induced by PGE〗，in which 4 genes had 
shown more than four-fold increase. There were 11 genes with detectable 
hybridization signals in PGE2 induced cells but none in the uninduced cells. They 
were considered to be PGE, induced genes. On the other hand, a total of 59 genes 
were showed to be down regulated or repressed by PGE?. 56 genes were down 
regulated by more than two-fold, in which 26 of them were down regulated by more 
than four-fold. 3 genes were with detectable hybridization signals in uninduced 
cells but none in the PGE: induced cells, and they were considered to be repressed 
by PGE,. 
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Figure 4.1 Gene orientation on the Atlas™ Mouse cDNA Expression Array. 
Block A includes oncogenes, tumor suppressors and cell cycle regulators. Block B 
includes stress response, ion channels & transport genes, also with modulators, 
effectors & intracellular transducers. Block C includes genes responsible for 
apoptosis, DNA synthesis, repair & recombination. Block D includes transcription 
factors & DNA-binding proteins. Block E includes receptors for growth factor & 
chemokine, interleukin & interferon，hormone and also neurotransmitter. Cell 
surface antigens and cell adhesion genes are also included. Finally, block F 
includes genes that are involved in cell-cell communication. They are groups of 
growth factors, cytokines & chemokines，interleukins & interferons and also 
hormones. Genes relate to cytoskeleton & motility and protein turnover are also 
included in block F. Block G includes groups of housekeeping genes and negative 
controls. Dark gray dots represent genomic DNA spots that serve as orientation 
marks and help to determine the coordinates of hybridization signals. (Copy from 
user manual of Clontech cat.7741-1) 
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Figure 4.2 Hybridization signals detected on the Atlas Array membranes. 
Radioactivity labeled cDNA probes sythesized from uninduced and PGE: induced 
JCS cells were hybridized to two Atlas Array membranes (shown as A & B 
respectively). Hybridization signals were detected by autoradiography (72 hours 
exposure at -70 °C). 
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Table 4.2 Numerical representation of hybridization signals of uninduced JCS cells 
by Lumi-imager analysis system. 
Block A 
i 2 3 4 5 6 7 
^ a 0 0.013766 0.442954 67.2391 0.258627 0 0.000853 
b 0 0.018365 5.71528 0.652965 0.009763 0.015077 0.020562 
c 0.461955 0.001817 0.072433 0 0.650626 2.9433 0.030111 
d 0.010087 0 0 0 0.073439 1.901765 0.518397 
e 0.22275 0 0 0 0.099929 1.813495 1.134707 
f 10.82455 0.060372 0 0.013265 0.870041 1.52257 0.898654 
g 0.09362 0.0521 0.851391 3.48498 0.138408 2.591805 0.309143 
h 0.179139 0.010512 0.027869 0.094209 0.019246 0.29725 2.11515 
i 0.293753 2.15282 0.047576 0 0.0965 2.51519 0.070776 
j 0.752708 69.12285 0.020647 0.100202 0.140368 0.48611 0.304611 
k 0.425111 4.963925 0.311352 1.919475 0.17436 0.584477 0.446213 
1 0.771968 68.751 0.608693 0.246182 0.272865 0.989573 11.649 
m 0.404888 3.039555 0.56935 0.015704 0.253563 3.662649 30.23275 
n 0.834893 0.173485 13.16585 0.085595 0.166703 0.937349 13.17465 
Block B 
i 2 3 4 5 6 7 
a 0.488763 0.017975 0 0.0583^  0 0.509583 0.083208~ 
b 4.85536 0.011867 0 0.000853 0.011146 0.284169 0.51169 
c 丨 4.1973 0.075327 0 0.493517 0.086915 0.243504 0.150387 
d 62.42835 0.124354 0.(K)427 0.306033 l.%143 0.064599 0.()637W 
c 1.50404 0.111562 0.000853 0.045059 0.148245 0.17787 0.433505 
f {),()46546 0.010256 0.06464X ().()71{)48 0.022027 0.316151 1.564345 
g 0.073185 0.110784 0.339726 0.023307 0.04505 2.40871 7.()4W85 
h 1.8(i2()05 0.1606 K4 U. 112083 0.074234 0.16637^； 0.127318 0.672118 
i 0.315871 0.1417… 0.0730% 2.(XK>43 7.58777 0.18^ 879 3.560195 
j 0.233 0.(W1616 0.012846 0 . 1 1 . 0 4 5 6 8 5 0.305177 0.408349 
k 1.45110.228W52 0.1 HI 106 0.145821 n.lK4156 0.4321K4 0.151S84 
1 OW7h7 0.1142K7 0.047714 0.1W4S1 0.453474 0.141778 0.25WH4 
m 4.16561 0.245446 (WWW 0.421654 5.1^ 5(^ 5 0.04K978 0.317'>S2 
n 0.130772 0.410622 0,355437 1,32713 0.345^ 83 0.475351 
Block C 
- 2 3 4 5 6 7 
a 0.446945 1.554505 0.51786^  0404^ 0.423801 2.372305 0.550004 
h 0.7S4106 ~1.74g： 0.45 ISIS 1.357415 0.55W26 0,541218 l.fX)2179 
c 0.22235： 3.M44-5 0.^ 16834 59.^ 535 0.565451 0.33824 0.48K543 
d 0.1S45S8 1.3154- 0.:4MK3 3.8^X124 0.368229 0.1851 
e 0.66W3 0,4IS 10.1! IS" 0.444233 1.021824 0.488815 
f 1.42S<>4.S 0.263^ 1^ 0.3319 0:4:叫 si 0.537764 0.45r)011 0.727009 
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Continue table 4.2 
g 0.770016 0.147225 0.503517 0.186523 0.493518 0.202573 0.330718 
h 0.106673 0.563452 1.72844 0.526231 1.078092 0.438839 0.132653 
i 0.205334 0.19058 0.311889 0.702845 0.339412 2.083335 0.426248 
j 0.199713 0.673613 0.451046 1.126477 0.488507 70.2406 0.696773 
k 0.284927 6.624715 0.279481 0.329375 0.237796 1.78829 0.149566 
1 0.371702 0.237037 0.480809 0.356304 0.487908 0.135459 0.590055 
m 4.7517 0.29226 0.355263 0.441069 0.559766 0.536922 0.466879 
n 0.370527 0.256188 0.201068 0.148288 0.297261 0.290428 0.966133 
Block D 
i 2 3 4 5 6 7 
^ a 0.58495 0.292777 0.453835 0.452453 0.9299 0.50472 0.284994 
b 0.052642 0.380704 0.597905 0.82368 0.457726 0.190474 0.183255 
c 0.350796 0.297565 0.147671 0.211307 0.421864 0.104947 0.3273 
d 0.111423 1.142402 1.384115 0.423062 0.456088 0.547663 0.180594 
e 0.427943 0.555438 0.193804 0.315089 0.351135 0.111241 1.59392 
f 0.303952 1.560845 0.398719 1.20047 1.065322 0.601968 0.2048% 
g 0.352401 14.4359 0.741928 0.780772 5.197695 0.647746 0.294049 
h 0.345124 1.226364 0.295363 0.747266 2.2724 2.00096 1.77409 
i 0.315505 0.236333 0.342131 0.5653% 0.270005 0.755323 2.35463 
j 0.515998 1.609695 0.402568 0.291977 0.120077 0.54092 66.34865 
k 0.43295 0.598391 0.231234 0.151704 0.131491 1.130899 2.586165 
I 0.61962 0.721854 0.369536 0.863555 0.%2279 12.19685 0.150021 
m 0.5487 0.464587 0.305468 0.23974 10.00823 0.572601 0.528274 
n 0.2% 145 0.818^93 0.494451 0.109927 0.632723 0.263593 0.698832 
Block E 
. 2 3 4 5 6 7 
a 0.152024 0.3745^3 0.270162 0.8()32W 0.469584 0.323445 0.239351 
b 0.465357 0.281569 0.513693 0.244314 0.175585 0.127263 0.988822 
c ()._S(>4 0.26S3M 0.24886^ ； 0.150(W5 0.347109 0.367764 0.32W56 
d (UWO^ ().6()54W 0.28CN17 0.345143 0.^38417 0.35351 
c 0.1824 7S 7.084715 ().27704,S 0.38^551 0.095738 1.11717 0.16571S 
f 0.257532 0.W23183 0.466026 ().3()0(K)7 0.1 S750.S 0.192017 
g 0.344647 1.452245 ().47S4:i 0.110162 ().5W)6()2 1 . 4 5 W 5 
h ().54:7M 0.252K14 0.215(XN 0.325056 5.5hM f).24K/)()5 
1 (UMW 0.154S35 O.S57537 0.305^6： ().3S3442 0.243477 (M55H21 
j 0.456713 0.? 19601 0.286^ 7^7 0.7143� 0.148451 1.14348'> 
k OJlOO-叫 0.268075 ().2ASS2 0.37W16 0.183854 0.351XS7 
1 0.30745(1 0.283：01 0.6：714： 0.21745： 0.28W43 0.44561 0.531H63 
m 0.52274 0.165 0.414821 0.:v6007 0.286f)82 0.78m 97 0.3750H7 
n 0.674306 0.44,^ ^ S3 0.36^ 5^16 0.25 二 a:、_S5 1.2.H4055 0.302722 
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Continue table 4.2 
Block F 
i 2 3 4 5 6 7 
^ a 0.162325 0.644314 56.07875 0.741376 0.504424 0.578101 0.37561 
b 0.342315 0.408701 2.3012 0.158712 0.547115 0.919065 0.368889 
c 0.543963 0.422153 0.313295 0.286238 0.340721 1.12164 0.201347 
d 0.125429 0.296304 0.777938 0.277793 0.451428 50.3389 0.459103 
e 0.455 0.111265 1.999595 0.354895 0.520976 2.628635 0.383485 
f 0.247258 0.494473 0.851205 5.587695 0.406627 0.236608 0.268955 
g 0.356573 0.513116 0.040499 0.693533 0.275408 0.233033 0.299104 
h 0.260597 0.942716 0.940662 0.776971 0.887363 4.73893 0.890703 
i 0.376094 0.601718 0.177025 0.214564 0.49017 0.494822 0.369687 ‘ 
j 0.413058 0.106033 0.390503 0.111397 0.594555 0.588248 0.379769 
k 0.288918 0.777663 0.268587 0.499681 0.217301 0.411641 0.393322 
1 0.56763 19.10555 3.34124 0.989971 0.337494 1.255305 0.585042 
m 0.385393 0.999572 69.93285 0.525655 0.303097 0.309282 0.589157 
n 0.344827 0.336934 0.889139 0.472379 0.121411 0.518981 1.167505 
Block G 
i 2 3 4 5 6 7 
1.759868 0.677561 0.43631 9.099698 0 21.48345 1.34204 
Block G 
8 9 10 n 12 13 14 
0.83316 0.375712 0.18402 0.442994 39.8923 0.668787 1.528815 
Block G 
15 16 17 18 19 W 21 
0.291833 0.419461 1.365337 65.27545 3.387245 39.00655 2.323998~ 
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Table 4.3 Numerical representation of hybridization signals of PGE2 induced JCS 
cells by Lumi-imager analysis system (raw data). 
Block A 
i 2 3 4 5 6 7 
a 1.638105 0.437832 1.542155 76.8122 1.129665 0.539878 0 .381726^ 
b 0.209165 0.669581 25.57145 1.005356 0.525244 0.625577 0.360537 
c 1.309597 0.381134 0.805219 1.208795 2.78821 21.0985 0.306702 
d 0.420055 0.506984 2.370695 0.453357 0.364236 2.443095 1.014582 
e 6.579465 0.033395 0.828058 1.315675 0.567682 0.235127 2.50329 
f 25.80345 1.8212 0.331096 0.488032 1.645755 0.726735 1.421446 
g 0.540505 3.106345 14.6817 32.10365 0.505759 21.132 0.384644 
h 0.624227 0.85601 0.360876 1.41399 0.144809 0.427418 4.995385 
i 1.01132 20.61565 0.758138 0.418947 0.370734 3.264135 0.378288 
j 3.747691 20.5256 1.432127 7.904125 0.314279 0.812809 1.66779 
k 0.75215 24.06775 1.468805 9.648685 0.336339 4.35627 0.606294 ‘ 
1 1.218362 48.65855 7.311585 1.67592 0.593088 2.470312 18.969 
m 1.022117 3.980755 0.993945 0.200889 0.855549 8.562815 8.343555 
n 2.50537 0.675249 45.5211 2.30208 0.840281 22.3248 33.9816 
Block B 
i 2 3 4 5 6 7 
a 1.128095 0.301081 0.516947 0.451365 0.253702 1.31985 0 .211856^ 
b 14.15 0.506716 0.290548 0.534979 0.306403 0.589126 2.351985 
c 38.36865 0.58723 0.232551 1.939765 0.407865 1.348415 0.351707 
d 33.19035 0.666981 0.541618 1.215362 2.55877 0.283511 0.424441 
e 10.12207 0.603635 0.075897 0.7425 0.930737 0.15525 0.679109 
f 0.584586 0.291517 0.862268 0.415531 0.086848 0.927984 2.142905 
g 0.696557 0.552852 0.318959 1.338645 0.200437 8.274415 48.4032 
h 1.47124 0.281187 0.409713 0.181503 0.917946 0.379019 0.743167 
I 1.356325 0.178655 1.10844 1.327175 32.55835 0.35589 4.48705 
j 1.050725 0.500505 0.265389 1.016954 2.25573 0.528182 0.60266 
k 7.26539 0.400244 0.259455 0.974567 0.218009 8.722875 0.338321 
1 3.30155 0.222157 0.375327 0.148834 0.749202 0.236928 0.350758 
m 8.30075 0.151782 0.252909 0.728431 34.6776 0.231563 0.469394 
n 0.636349 0.433591 0.70825 0.572646 4.915625 0.334801 2.84094 
Block C 
1 2 3 4 5 6 7 
a 0.636579 22.5345 0.861763 0.441351 0.650567 3.674725 0.19663 
b 2.040961 33.90975 2.121711 1.37401 0.713748 1.154395 1.121095 
c 1.001883 7.056705 2.203255 44.8953 1.358471 0.196422 0.486993 
d 0.364526 1.92071 1.075471 21.54475 11.1842 0.351022 0.147702 
e 4.668655 0.379014 3.906185 14.12855 0.882221 0.405446 0.433581 
f 5.09516 0.285362 0.752206 53.938 1.186281 0.51366 0.85433 
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Continue table 4.3 
g 3.317685 0.73236 0.387741 5.157375 0.487499 0.329389 0.619967 
h 0.283362 0.617033 4.285645 0.335833 1.23673 0.281933 0.297779 
I 0.634019 0.420593 0.370347 0.67602 0.489112 6.9202 0.854352 
j 0.386447 0.848231 1.68139 3.87604 0.813327 57.374 3.954255 
k 0.964827 43.4433 0.297966 0.455457 0.520697 2.743495 0.778826 
1 0.693236 0.363791 0.914749 0.486247 0.513052 0.327087 0.319162 
m 57.14785 0.28222 0.082948 0.266808 0.716001 0.249385 0.507897 
n 0.869302 0.261238 0.348891 0.297486 0.579963 0.540163 0.326849 
Block D 
i 2 3 4 5 6 7 
a 0.667516 0.612085 0.295847 0.563366 0.436694 2.749425 0.606078 
b 0.193578 0.152378 0.677659 8.36446 0.091489 0.516508 0.329199 
c 0.312822 0.461062 0.518104 0.349845 1.202152 0.423033 0.326272 
d 0.620641 2.7774 6.50989 1.482235 0.205329 0.496045 0.147669 
e 0.225245 1.055106 0.977373 0.417159 0.072488 0.062946 2.715875 
f 0.292258 1.371635 1.290415 0.304139 0.256276 0.290369 0.216425 
g 0.244817 59.2625 0.859876 0.473573 0.1977 0.881074 0.658191 
h 0.166559 1.704545 0.466996 2.46529 3.13758 4.18993 2.49771 ‘ 
I 0.375803 0.38632 0.264342 1.297758 0.468602 0.904027 3.37561 
j 2.515805 2.809135 0.909589 0.605141 1.159878 1.900185 39.3005 
k 0.447122 0.473789 0.329395 0.347895 0.331501 3.422945 13.23205 
1 0.169324 1.653095 0.642859 6.06166 2.002515 41.36345 0.488661 
m 1.902625 0.934897 1.30843 0.427279 80.52895 0.939399 0.137922 
n 0.302414 0.400089 1.328514 25.8316 2.769275 0.442417 0.070139 
Block E 
i 2 3 4 5 6 7 
a 0.454472 0.390477 0.319145 1.719405 0.213899 0.550679 0.493429 
b 0.661378 0.243894 0.158603 0.30355 0.164641 0.39572 0.762686 
c 0.36929 0.30019 0.869005 0.127939 0.229023 0.345698 1.166184 
d 0.207959 1.60395 18.2112 1.86445 0.899834 3.206795 0.617663 
e 0.682629 77.25815 1.019236 0.381998 0.269129 2.66528 0.348272 
f 0.624902 1.91831 0.28601 0.426139 0.221196 0.503292 0.618643 
g 0.37937 5.191375 0.144104 0.403952 0.469175 2.308835 6.525185 
h 0.602936 0.364771 21.43805 10.52145 8.232785 54.95315 0.945623 
I 0.849424 0.52661 0.586907 0.699285 4.28709 7.54827 0.192039 
j 0.167145 0.659423 0.10475 1.555706 1.415139 0.324833 3.867405 
k 0.054046 0.083023 0.480441 0.442339 0.098674 0.383862 0.216932 
1 0.021378 0.116152 1.46112 4.82696 1.558565 0.142023 0.540752 
m 0.000853 0.044582 1.46434 0.399888 0.021836 2.632525 0.006836 
n 0.399321 0.176288 0.277694 0.513729 2.714015 4.272395 0.093214 
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Continue table 4.2 
Block F 
i 2 3 4 5 6 7 
a 0.280608 0.862047 66.4425 1.839326 0.231832 0.992692 0.63977 ‘ 
b 0.69081 0.515323 2.867665 0.247336 0.170171 4.81078 0.67076 
c 0.833321 0.319682 0.76401 0.895289 0.227464 1.858515 0.117448 
d 0.672196 0.445773 0.549174 0.582851 0.23501 69.99665 0.701057 
e 0.472477 0.344416 10.93285 0.576417 0.144655 6.40621 0.5212 
f 0.320267 0.386272 14.1587 51.3367 0.433479 0.635613 0.3257 
g 0.367902 0.502468 0.92307 1.824125 0.34593 1.372485 0.102478 
h 0.529142 4.66591 1.933905 2.442275 0.449219 28.3267 5.078695 
I 0.292199 0.839013 0.201285 0.428107 0.15683 1.51576 0.63265 
j 0.39092 0.289547 0.897977 0.243687 0.10077 1.28198 0.226594 
k 0.372626 0.3496 0.066767 0.638392 0.572779 0.339066 0.638309 
1 0.951115 71.30025 17.2398 0.753696 0.705679 2.05372 4.35499 
m 0.168764 1.67679 51.6904 1.048521 0.097109 0.484901 0.248329 
n 0.049803 0.243142 4.231735 0.309849 0.044417 0.72319 1.123115 
Block G 
i 2 3 4 5 6 7 
0.135709 0.495289 1.397894 18.7745 0 33.86655 1.145023 
Block G 
8 9 10 n 12 13 14 
0.06239 4.201525 21.29342 8.54215 5.22791 6.996978 
Block G 
15 16 17 18 19 n 
0.037069 0.203618 4.032677 16.79155 24.16905 0 14.18018 
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Table 4.4 Numerical representation of hybridization signals of PGE? induced JCS 
cell by Lumi-imager analysis system (normalized data). 
Block A 
i 2 3 4 5 6 7 
a 0.229578 0.061361 0.21613 10.7651 0.158321 0.075663 0.053498 
b 0.029314 0.093841 3.583795 0.140899 0.073612 0.087673 0.050529 ‘ 
c 0.183538 0.053415 0.11285 0.169411 0.390763 2.956918 0.042984 
d 0.05887 0.071053 0.332249 0.063537 0.051047 0.342396 0.142192 
e 0.922101 0.00468 0.116051 0.18439 0.07956 0.032953 0.350832 
f 3.616309 0.255238 0.046402 0.068397 0.23065 0.101851 0.199213 
g 0.075751 0.435349 2.057615 4.499271 0.070881 2.961613 0.053907 
h 0.087484 0.119968 0.050576 0.198168 0.020295 0.059902 0.700095 
I 0.141735 2.889248 0.106252 0.058715 0.051958 0.457463 0.053016 
j 0.525232 2.876627 0.20071 1.107749 0.044046 0.113914 0.233738 
k 0.105413 3.373054 0.20585 1.352247 0.047137 0.610524 0.084971 
1 0.170751 6.819412 1.024706 0.234877 0.08312 0.34621 2.658473 
m 0.143248 0.557896 0.1393 0.028154 0.119904 1.200064 1.169335 
n 0.351123 0.094635 6.379704 0.322633 0.117764 3.128782 4.762463 
Block B 
1 2 3 4 5 6 7 
a 0.158101 0.042196 0.072449 0.063258 0.035556 0.184975 0.029691 
b 1.983098 0.071015 0.04072 0.074976 0.042942 0.082565 0.329627 
c 5.3773 0.082299 0.032592 0.271855 0.057162 0.188978 0.049291 
d 4.65157 0.093476 0.075907 0.170331 0.358607 0.039734 0.059485 
e 1.41859 0.084598 0.010637 0.10406 0.130441 0.021758 0.095176 
f 0.081929 0.040856 0.120845 0.058236 0.012172 0.130055 0.300324 
g 0.097621 0.077481 0.044701 0.187609 0.028091 1.159645 6.783625 
h 0.206192 0.039408 0.057421 0.025437 0.128649 0.053119 0.104154 
I 0.190087 0.025038 0.155346 0.186001 4.562997 0.049877 0.628852 
j 0.147257 0.070145 0.037194 0.142524 0.316137 0.074024 0.084462 
k 1.018232 0.056093 0.036362 0.136584 0.030554 1.222496 0.047415 
1 0.462707 0.031135 0.052601 0.020859 0.104999 0.033205 0.049158 
m 1.163336 0.021272 0.035445 0.102088 4.860006 0.032453 0.065785 
n 0.089183 0.060767 0.09926 0.080255 0.688916 0.046922 0.398153 
Block C 
1 2 3 4 5 6 7 
a ~0.089215 3.158171 0.120775 0.061855 0.091176 0.515006 0.027557 
b 0.286037 4.752393 0.297354 0.192565 0.10003 0.161786 0.15712 
c 0.140412 0.988985 0.308782 6.291999 0.190387 0.027528 0.068251 . 
d 0.051088 0.269184 0.150725 3.01946 1.567446 0.049195 0.0207 
e 0.654304 0.053118 0.547445 1.980092 0.123642 0.056823 0.060766 
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f 0.714078 0.039993 0.10542 7.559318 0.166255 0.071989 0.119733 
g 0.464968 0.102639 0.054341 0.722797 0.068322 0.046163 0.086887 
h 0.039713 0.086476 0.600626 0.047066 0.173326 0.039512 0.041733 
I 0.088857 0.058945 0.051903 0.094743 0.068548 0.969854 0.119736 
j 0.05416 0.118878 0.235644 0.54322 0.113986 8.040867 0.554182 
k 0.135219 6.088504 0.041759 0.063831 0.072975 0.384496 0.109151 
1 0.097156 0.050985 0.1282 0.068147 0.071903 0.045841 0.04473 
m 8.009173 0.039553 0.011625 0.037393 0.100346 0.034951 0.071181 
n 0.121831 0.036612 0.048896 0.041692 0.081281 0.075703 0.045807 
Block D 
i 2 3 4 5 6 7 
a 0.093551 0.085783 0.041462 0.078955 0.061202 0.385327 0.084941 
b 0.02713 0.021355 0.094973 1.172265 0.012822 0.072388 0.046137 
c 0.043841 0.064617 0.072611 0.04903 0.16848 0.059287 0.045726 
d 0.086982 0.389248 0.91235 0.207733 0.028777 0.06952 0.020695 
e 0.031568 0.147871 0.136977 0.058464 0.010159 0.008822 0.380625 
f 0.040959 0.192232 0.180849 0.042625 0.035917 0.040695 0.030332 
g 0.034311 8.305537 0.12051 0.06637 0.027707 0.123481 0.092244 
h 0.023343 0.238889 0.065449 0.345506 0.439726 0.587211 0.35005 
I 0.052668 0.054142 0.037047 0.181879 0.065674 0.126698 0.473086 
j 0.352586 0.393695 0.127477 0.084809 0.162555 0.266308 5.507897 
k 0.062663 0.066401 0.046164 0.048757 0.046459 0.47972 1.854449 
1 0.02373 0.231678 0.090096 0.849531 0.280649 5.797016 0.068485 
m 0.26665 0.131024 0.183374 0.059882 11.28599 0.131655 0.01933 
n 0.042383 0.056072 0.186189 3.620254 0.388109 0.062004 0.00983 
Block E 
1 2 3 4 5 6 7 ‘ 
a ~0.063693 0.054725 0.044728 0.240972 0.029978 0.077177 0.069153 
b 0.092691 0.034181 0.022228 0.042542 0.023074 0.055459 0.106889 
c 0.051755 0.042071 0.12179 0.01793 0.032097 0.048449 0.163439 
d 0.029145 0.224791 2.552268 0.261299 0.12611 0.449427 0.086564 
e 0.095669 10.8276 0.142844 0.053536 0.037718 0.373534 0.04881 
f 0.087579 0.268848 0.040084 0.059723 0.031 0.070536 0.086702 
g 0.053168 0.727562 0.020196 0.056613 0.065754 0.323579 0.914493 
h 0.0845 0.051122 3.004506 1.474563 1.153811 7.701589 0.132527 
I 0.119045 0.073803 0.082254 0.098004 0.600828 1.057877 0.026914 
j 0.023425 0.092417 0.01468 0.218029 0.198329 0.045525 0.54201 
k 0.007574 0.011635 0.067333 0.061993 0.013829 0.053798 0.030403 
1 0.002996 0.016278 0.204773 0.67649 0.21843 0.019904 0.075785 
m 0.00012 0.006248 0.205225 0.056044 0.00306 0.368944 0.000958 
n 0.055964 0.024706 0.038918 0.071998 0.380365 0.598769 0.013064 
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Block F 
i 2 3 4 5 6 7 
a 0.039327 0.120814 9.311802 0.257778 0.032491 0.139124 0.089663 
b 0.096816 0.072222 0.401898 0.034664 0.023849 0.674223 0.094006 
c 0.116788 0.044803 0.107075 0.125473 0.031879 0.260468 0.01646 
d 0.094207 0.062474 0.076966 0.081686 0.032936 9.80991 0.098252 
e 0.066217 0.048269 1.53222 0.080784 0.020273 0.897819 0.073045 
f 0.044885 0.054135 1.984317 7.19475 0.060751 0.08908 0.045646 
g 0.051561 0.07042 0.129367 0.255648 0.048481 0.192351 0.014362 
h 0.074158 0.653919 0.271033 0.342281 0.062957 3.969938 0.71177 
I 0.040951 0.117586 0.02821 0.059998 0.021979 0.212431 0.088665 
j 0.054787 0.040579 0.12585 0.034152 0.014123 0.179667 0.031757 
k 0.052223 0.048996 0.009357 0.089469 0.080274 0.04752 0.089458 
1 0.133297 9.992607 2.416128 0.105629 0.0989 0.287825 0.610344 
m 0.023652 0.234999 7.24432 0.146948 0.01361 0.067958 0.034803 ‘ 
n 0.00698 0.034076 0.59307 0.043425 0.006225 0.101354 0.157403 
Block G 
1 2 3 4 5 6 7 
0.019019 0.069414 0.195912 2.631214 0 4.746338 0.160473 
Block G 
8 9 10 n 12 13 14 
0.008744 0.588836 2.984236 1.197168 0.732683 0.980614 2.437038 
Block G 
15 16 17 18 19 ^ E 
0.005195 0.028537 0.565173 2.353307 3.387251 0 1 .987327^ 
Hybridization signals were analyzed by Lumi-imager analysis system. Intensities 
were calculated by taking the mean value of the 2 duplicated dots. Normalization 
factor calculated from the beta-actin control was multiplied to the raw data of PGE? 
induced samples. The normalization factor was 0.14. 
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Table 4.5 Fold of change in signal intensities of PGE� induced JCS cell sample 
comparing to the uninduced JCS cell control. 
Block A 
i 2 3 4 5 6 7 
^ a 0.229578/ND ^ 0.21613/0 0.160102 ^ ^ ND 
b ND ND 0.627055 ND ND ND ND 
c 0.397307 ND ND 0.169411/ ND 0.600595 1.004627 ND 
d ND ND 0.332249/ND ND ND 0.180041 0.142192/ND 
e 4.139623 ND ND 0.18439/ ND 0.07956/ ND ND 0.350832/ ND 
f 0.334084 4.227755 ND ND 0.265102 ND ND 
g ND 8.356027 2.416769 1.291046 ND 1.142684 ND 
h ND ND ND ND ND ND 0.330991 
i ND 2.889248/ND ND ND ND 0.18188 ND 
j ND 0.041616 ND 11.05516 ND ND 0.233738/ ND 
k ND 0.679513 0.20585/ ND 0.704488 ND 0.610524/ ND ND 
1 ND 0.09919 1.024706/ND 0.234877/ ND ND ND 0/11.649 
m 0.143248/ ND ND ND ND ND 1.200064/ND 0.038678 ‘ 
n 0.42056 ND 0.484565 0.322633/ND ND 3.128782/ND ND 
Block B 
i 2 3 4 5 6 7 
a ^ ND ND 0.362993 
b 0.408435 ND ND ND ND ND 0.329627/ND 
c 0.378755 ND ND 0.550852 ND 0.188978/ ND ND 
d 0.074511 ND ND 0.556577 0.182829 ND ND 
e ND ND ND 0.10406/ND ND ND ND 
f ND ND ND ND ND ND 0.191981 
g ND ND ND 0.187609/ ND ND 0.481438 0.962218 
h 0.110737 ND ND ND ND ND ND 
i 0.190087/ ND ND 0.155346/ ND 0.092981 0.601362 ND 0.176634 
j ND ND ND 0.142524/ND 0.302325 ND ND 
k 0.701679 ND ND ND ND 2.828647 ND 
1 0.492364 ND ND ND ND ND ND 
m 0.279271 ND ND 0.102088/ ND 0.935499 ND ND 
n ND ND 0.09926/ ND 0.080255/ ND 0.519102 ND 0.837598 ‘ 
Block C 
1 2 3 4 5 6 7 
a 而 ^ ^ ^ 0.217091 
b ND 0.066236 ND ND ND ND ND 
c ND ND ND 0.104875 ND ND ND 
d ND 0.269184/ND ND ND 0.402918 ND ND 
e 0.654304/ ND ND 0.31328 0.195819 ND ND ND 
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f 0.499828 ND ND 7.559318/ ND ND ND ND /0.727009 
g 0.464968/ ND ND ND ND ND ND ND 
h ND ND 0.347496 ND 0.160771 ND ND 
i ND ND ND 0.094743/ ND ND ND ND 
j ND ND 0.235644/ ND 0.482229 ND 0.114476 0.554182/ND 
k 0.135219/ ND 0.919059 ND ND ND ND ND 
1 ND ND 0.1282/ ND ND ND ND ND 
m 1.685538 ND ND ND ND ND ND 
n ND ND ND ND ND ND ND 
Block D 
1 2 3 ~ 4 5 6 7 
a ^ ^ ND /0.452453 ^ ND ^ 
b ND ND ND 1.172265/ ND ND ND ND 
c ND ND ND ND 0.16848/ ND ND ND 
d ND 0.340728 0.659158 0.491023 ND ND ND 
e ND 0.147871/ ND ND ND ND ND 0.238798 
f ND ND ND ND ND ND ND 
g ND 0.575339 ND ND ND 0.123481/ ND 0.092244/ND 
h ND ND ND 0.46236 0.193507 0.293465 0.197312 
i ND ND ND 0.321684 ND 0.126698/ND ND . 
j 0.352586/ ND 0.244577 0.127477/ND 0.084809/ ND ND ND 0.083014 
k ND ND ND ND ND 0.424193 ND 
1 ND 0.231678/ND ND 0.98376 ND 0.475288 ND 
m 0.26665/ ND 0.131024/ND 0.183374/ND ND 1.127671 ND ND 
n ND ND ND ND ND ND ND 
Block E 
i 2 3 4 5 6 7 
a 而 ND 0.299978 m ND ^ 
b ND ND ND ND ND ND ND /0.988822 
c ND ND ND ND ND ND ND 
d ND ND 1.73694 0.261299/ ND 0.12611/ ND 0.47892 ND 
e ND 1.527226 ND ND ND 0.334357 ND 
f ND 0.268848/ ND ND ND ND ND ND 
g ND 0.500974 ND ND ND ND 0.626633 
h ND ND 1.022236 1.474563/ ND 1.153811/ ND 1.383461 ND 
i ND ND ND ND ND ND ND 
j ND ND ND ND ND ND 0.473997 ‘ 
k ND ND ND ND ND ND ND 
1 ND ND 0.204773/ ND 0.67649/ ND 0.21843/ ND ND ND 
m ND ND 0.205225/ ND ND ND 0.368944/ ND ND 
n 0.055964/ ND ND ND ND 0.380365/ ND 0.598769/ ND ND 
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Block F 
i 2 3 4 5 6 7 
a ^ 而 0.166049 ^ 0.139124/ ND m 
b ND ND ND ND ND 0.733597 ND 
c ND ND ND ND ND ND ND . 
d ND ND ND ND ND 0.194877 ND 
e ND ND 0.766265 ND ND ND ND 
f ND ND 1.984317/ND 1.287606 ND ND ND 
g ND ND ND ND ND ND ND 
h ND 0.693654 0.28813 0.342281/ ND ND 0.837729 0.79911 
i ND ND ND ND ND ND ND 
j ND ND 0.12585/ ND ND ND 0.179667/ND ND 
k ND ND ND ND ND ND ND 
1 ND 0.523021 ND ND ND 0.287825/ ND 0.610344/ ND 
m ND ND 0.10359 ND ND ND ND 
n ND ND ND ND ND ND ND 
Block G 
i 2 3 4 5 6 7 
^ ^ ^ ^ ND (signal too 0.22093 ND  
high) 
Block G 
8 9 10 i i 12 13 14 
^ ^ r ^ ^ 0.018367 ^ 1 . 5 9 4 0 7 ^ 
Block G 
15 16 17 18 19 ^ n 
ND ND ND ND 1.000 ND 0.855133 
The fold of change was calculated by dividing the normalized signal intensity of 
PGE2 induced JCS cells with the signal intensity of uninduced JCS cells. Before 
making such calculation, signals of the two samples that could not be seen on film 
by naked eyes were screened out. After the screening process, only the signals 
with intensity more than two-fold background were counted. Background was 
calculated by taking mean of 56 blank spots from different regions of the film. 
Two-fold background for uninduced cell and PGE: induced cell signal was 0.60 and 
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0.64 respectively. The S.D. of the background was 0.17 and 0.15. Some signals, 
although could be seen by naked eyes and exceed two-fold background, were 
obviously made by artifacts. They were also ignored and not took into 
consideration. False positive results were thus ignored. In Table 4.5, signals that 
were screened out were expressed as ND (No detectable signal). Fold of change of 
expressed gene was presented as intensity in PGE? induced sample over ND. It 
was the same as the repressed genes. 
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Table 4.6 Regulated genes showed in the JCS cells after 5 hours PGE2 induction 
Category Gene Gene description Fold of 
number changes 
A. Genes with more than A l e EBl APC-binding protein 4.14 
four-fold increase A2f B-myb proto-oncogene; myb-related protein B 4.23 
A2g c-ErbA oncogene; thyroid hormone receptor 8.36 
A4j Vascular endothelial growth factor receptor 1 11.01 
(VEGFR 1); fms-related tyrosine kinase (Fltl) 
B. Genes with more than A3g jun-D; c-jun-related transcription factor 2.42 
two-fold increase B6k Phosphatidylinositol 3-kinase regulatory alpha 2.83 
subunit (PI3-kinase P85-alpha; . 
PTDINS-3-kinase P85-alpha; PI3K) 
C. Expressed genes after A2i c-Jun proto-oncogene (transcription factor AP-1 
PGE2 induction component) 
A31 B-raf proto-oncogene 
A6m Cdk4; cyclin-dependent kinase 4 
A6n Cdk5; cyclin-dependent kinase 5 
Cle BCL2 binding athanogene 1 (BAGl) 
C4f PD-1 possible cell death inducer; Ig gene 
superfamily member 
D4b Homeobox protein 2.4 (Hox-2.4) 
E4h 5-hydroxytryptamine (serotonin) receptor le beta 
E41 Acetylcholine receptor delta submit 
E5h Glutamate receptor; ionotropic AMPA 1 
F3f Macrophage inflammatory protein 1 beta (Act 2) 
D. Genes with more than A2j Transcription termination factor 1 (TTF 1) 0.04 
four- fold decrease A21 c-myc proto-oncogene 0.09 
A4a Pim-1 proto-oncogene 0.16 
A6d Cyclin B2 (G2/M-specific) 0.18 
A6i Cyclin E (Gl/S-specific) 0.18 
A7m Prothymosin alpha 0.03 
Bid HSP86; heat shock 86-kDa protein 0.07 
Blh HMGl-related VDJ recombination signal binding 0.11 
Protein 
B4i Transcription factor AlO 0.09 
B5d Syk tyrosine-protein kinase (activated p21 0.18 
cdc42Hs kinase (ack)) 
B7f Vav; GDP-GTP exchange factor; proto-oncogene 0.19 
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B7i Dvl2; dishevelled-2-tissue polarity protein 0.18 
C2b Glutathione S-transferase 5 (GST5-5); 0.07 
GST mu (GSTM2) 
C4c Nucleoside diphosphate kinase B (NDP 0.10 
kinase B; NDK B); NM23-M2; NME2 
C4e P55cdc; cell division control protein 20 0.20 
C5h ATP-dependent DNA helicase II 70-kDa subunit; 0.16 
thyroid Ku (p70/p80) autoantigen p70 subunit; 
p70 Ku; lupus Ku autoantigen protein P70 
(TLAA; KU70); CTC box binding factor 75-kDa 
subunit (CTCBF; CTC75; XRCC6) 
C6a PA6 stromal protein; RAG 1 gene activator 0.22 
C6j MHR23B; Rad23 UV excision repair protein 0.11 
homolog; xeroderma pigmentosum group C 
(XPC) repair complementing protein 
D2j Elf-1 (Ets family transcription factor) 0.24 ‘ 
D5h Nuclear factor related to P45 NF-E2 0.19 
D7e Transcription factor SEF2 0.24 
D7h Transcription factor UBF 0.20 
D7j YBl DNA binding protein 0.08 
F3a Insulin-like growth factor-IA 0.17 
F3m Neuroleukin 0.10 
F6d \lmentin; intermediate filament protein 0.19 
E. Genes with more than A l e Breast cancer type 2 susceptibility protein 0.40 
two- fold decrease (BRCA2) 
Alf Ezrin; villin 2; NF-2 (merlin) related filament/ 0.33 
plasma membrane associated proten 
Aln TSGlOl tumor susceptibility protein 0.42 
A3n Casein kinase II (alpha subunit) 0.48 
A5f She transforming adaptor protein; Src homology 0.27 
2 (SH2) protein; SHB-related , 
A7h Wee l/p87; cdc2 tyrosine 15-kinase 0.33 
Bib Heat shock 60-kDa protein 1 (HSP60); 0.41 
chaperonin; GroEL homolog; mitochondrial 
matrix protein PI 
B lc HSP84 (heat shock 84-kDa protein) 0.38 
Bl l Etoposide induced p53 responsive (EI24)mRNA 0.49 
Blm 78-kDa glucose regulated protein (GRP 78) 0.28 
B5j Jak3 tyrosine-protein kinase; Janus kinase 3 0.30 
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B6a Dual-specificity mitogen-activated protein kinase 0.36 
kinase 1 (MAP kinase kinase 1; MAPK kinase 1; 
MAPKKl); erk activator kinase 1 (MEKl); 
PRKMKl 
B6g PKC-delta; protein kinase C delta type 0.48 
Clf Bak apoptosis regulator; Bcl-2 family member 0.50 
C3e Fas-associated factor 1 (FAF 1) 0.31 
C3h FLIP-L; apoptosis inhibitor; FLICE-like 0.35 
inhibitory protein 
C4j RIP cell death protein; Fas/APO-1 (CD95) 0.48 
interactor (contains death domain) 
C5d Tumor necrosis factor receptor 1 (TNFR-1) 0.40 
D2d Erythroid transcription factor NF-E2 0.34 
D4d Homeobox protein 3.1 (Hox-3.1) 0.49 
D4h Homeobox protein HOXD-3 0.46 
D4i Ikaros DNA binding protein 0.32 
D6h T-lymphocyte activated protein 0.29 
D6k Transcription factor CI 0.42 
D61 Transcription factor CTCF (11 zinc fingers) 0.48 
E4a Insulin receptor 0.30 
E6d CD31; platelet endothelial cell adhesion 0.48 
molecule 1 
E6e CD44 antigen 0.33 
E7j Lamimin receptor 1 0.47 
F3h Mad related protein 2 (MADR2) 0.29 
F. Repressed genes after A71 Myeloblastin; trypsin-chymotrypsin related serine 
PGE2 induction Protease 
C7f Rad50; DNA repair protein 
E7b Integrin alpha 4 




4.5.1 Genes with increased expression 
From the result, hybridization signals of 6 genes were showed to be 
upregulated for more than two-fold, in which 4 genes showed more than four-fold 
increase. There were 11 genes with detectable hybridization signals in PGE2 
induced cells but none in the uninduced cells. They were considered to be PGE: ^ 
induced genes. Among these genes, some were well known for their involvement 
in cell differentiation and cell cycle regulation and they may be discussed with more 
details. 
Oncogenes & tumor suppressors 
Most of the upregulated genes belong to the category of oncogenes and tumor 
suppressors. EBl APC-binding protein refers to the adenomatosis polyposis coli 
binding protein EBl. A new member of this gene family, RPl, is found to be 
differentially expressed in activated T cells (Renner et al” 1997). 
B'myb mRNA has been found to be expressed in all proliferating mammalian 
cell lines (Lane et al； 1997). Cyclin A/ cdk-2 mediated phosphorylated and 
protein truncation can markedly potentiate its transactivation activity (Lane et al., 
1997). In Swiss 3T3 and NIH 3T3 cells，B-MYB protein is detectable at all stages 
of the cell cycle, suggesting that B-myb may have a function throughout the cell 
cycle and in quiescent cells (Robinson et al., 1996). The gene shows marked 
homology to the c-myb DNA binding domain and is down regulated during terminal 
differentiation of haemopoietic and neuroblastoma cells. Constitutive expression 
of murine B-MYB protein in Ml cells abrogates the growth arrest, terminal 
differentiation, and associated apoptosis induced by IL-6 (Bies et al., 1996). The 
observation is different with ours. For JCS cells, PGE2 was found to inhibit the 
growth and drive the cell to differentiate into cells of monocytic lineage. 
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c-erbA encodes the thyroid hormone (T3) nuclear receptors (THRs) is thought 
to antagonize cell proliferation. Together with retinoic acid (RA) receptor, 
thyroid hormone receptors can interact to regulate gene expression. Early 
expression of unliganded T3 receptor-a has the function to modulate the RA 
response and RA-stimulated neural differentiation (Lee et al., 1994). 
Overexpression of c-erbA allows T3 to largely mimic the retinoic acid effects and 
enhances myogenic differentiation (Carnac et al” 1993). It seems that the 
expression of c-erbA is accompanied with cell differentiation. 
Vascular endothelial growth factor receptor-1 (vegfrl), which also termed 
FMS-like tyrosine kinase 1 or fltl，is another gene that showed a sharp increase in 
expression in PGE2 induced JCS cells. This receptor belongs to a subclass of 
tyrosine kinase receptors, which relate to the platelet-derived growth factor (PDGF) 
receptor. During organogenesis, vegfrl is expressed in most of the developing 
vascular structures and it is thought to have an important function both in the 
differentiation of the endothelial lineage and in the neovascularization of developing 
organs, and acts in a paracrine fashion (Breier et al., 1995). It also suggests that 
VEGFR 1 signaling pathway may regulate normal endothelial cell-cell or cell-matrix 
interactions during vascular development and it is essential for the organization of 
embryonic vasculature (Fong et al., 1995). -
AP-1 proteins are usually early response genes and not surprisingly, members 
of this family, jun-d and c-jun, were shown to be upregulated in the experiment. 
AP-1 consists of proteins from jun and fos families, which associates as homo-
(JUN/JUN) or heterodimers (FOS/JUN). They may bind to the AP-1 site and c-
JUN, JUN-b and JUN-d are similar in their DNA binding properties and in their 
interaction with FOS (Nakabeppu et al” 1988). AP-1 activity is generally 
associated with proliferation; it is also an important signaling component in various 
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differentiation processes involving growth arrest (Rezzonico et al., 1995). They 
may regulate other genes and there is a possible regulatory function for the Fra-2-
Jun-d API complex in a basal keratinocyte-specific gene (Virolle et al； 1998). 
Such genes may also take part in apoptosis (Marti et al” 1994，Pandey and Wang, 
1995). As jun-d and c-jun were both induced to express, and JUN protein may 
form heterodimer with each other, these two proteins may form dimer also and 
regulate the cell activity during the induced differentiation of JCS cells. 
h-raf belongs to the raf/uril family of serine/threonine protein kinases. It 
encodes serine/threonine protein kinases, which have shown to play a key role in 
signal transduction pathway from the membrane to the nucleus. b-RAF protein can 
be activated by growth factors in human and by IL-3 in mouse haemopoietic cell 
lines (Barnier et al., 1995). Though WEHI-3B JCS cell has the ability to produce 
IL-3, the induction of b-ra/seems not to relate to this as the induction time was only 
5 hours and only when the cells are overgrown can significant amount of IL-3 
produced. The b-RAF protein acts downstream of and upstream of MEK 
during signal transduction in PC12 cells and appears to be the major Mek kinase in 
nerve growth factor-stimulated PC12 cells (Barnier et al., 1995). In murine 
haemopoietic cell lines, one can notice the expression of b-raf easily and the protein 
can be involved not only in neural specific signal transducing pathway but also in 
those regulating proliferation and differentiation of haemopoietic precursors 
(Eychene et al, 1995). 
Cell cycle regulators 
Cyclin-dependent kinases (cdks) 4 and 5 were found to be expressed in PGE2 
induced JCS cells. Different CDKs exert their effect by associate with different 
cyclins. For example, CDK 4 and CDK 6 will associate with D-type cyclins and 
are activated by rearrangement or amplification in several tumors, and CDKs surely 
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play important roles in the regulation of the cell cycle (Kitagawa et al., 1996). 
Although CDKs may participate in multiple interactions with different cyclins, the 
nature or stoichiometry of these associations may differ in different types of cells 
(Bates et al； 1994). CDK 4 are a major catalytic partner of D-type G1 cyclins and 
D-type cyclin complexes have been strongly implicated in G1 growth control in 
several cell systems (Ando and Griffin, 1995). For CDK 5, it is a cdc-2 related 
protein kinase that is known to be highly expressed in mature brain and is mainly 
expressed in neurons that are terminally differentiated (Ino et al” 1994). cdk 5 is 
also expressed in cells undergoing apoptosis in various developmental models, 
including the embryonic nervous systems, eye, and interdigital regions of the limbs 
(Zhang et al” 1997)，and these strongly suggest the role of cdk 5 in apoptosis and 
differentiation. 
Modulators, effectors & intracellular transducers 
Phosphatidylinositol 3 kinase regulatory subunit, phosphoprotein P85 (PI3-K 
P85), together with the catalytic subunit PllO form the PI3 kinae which is a member 
of the platelet-derived growth factor (PDGF) signaling pathway. The activation of 
the subunit occurs after ligation of a broad range of receptors that leads to 
phosphorylation of the inositol ring at the D3 position. This results in the transient 
in vivo production of phosphatidylinositol 3,4- biphosphate and phosphatidylinositol 
3,4,5- triphosphate, which is thought to act as novel second messenger (Craddock 
and Welham, 1997). Solely P85 contains an SH3 domain and two SH2 domains 
that are homologous to domains found in several receptor-associated enzymes 
(Escobedo et al., 1991). The activation of P85 may activate PIS kinase and turn on 
different signaling pathway. 
Apoptosis-associated proteins 
BCL 2 binding athanogene 1 (BAGl) was orginally identified as a BCL-2 
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binding protein. It represents a new type of anti-apoptotic molecule that serves to 
prolong cell survival. BAG-1 involves directly in hepatocyte growth factor (HGF) 
and PDGF survival signaling pathway and the increased level of BAG-1 enhances 
HGF- and PGDF- induced protection from apoptosis in liver progenitor cells 
(Bardelli et al., 1996). Co-expression of BAG-1 and BCL-2 in Jurket lymphoid 
cells，NIH 3T3 fibroblasts promotes the survival of these cells in respond to a 
variety of apoptotic stimuli including staurosporine, anti-Fas antibody and cytolytic 
T cells (Takayama et al., 1995). BAG-1 can also regulate retinoid activities 
through its interaction with retinoic acid receptor and it is suggested that elevated 
levels of BAG-1 protein can potentially contribute to retinoid resistance in cancer 
cells (Liu et al., 1998). 
PD-1, the possible cell death inducer is a novel member of the immunoglobulin 
gene superfamily. The pd-l gene is activated in both of the two different types of 
lymphoid cell lines (2B4.11 and LyD9) when they are induced to die by the different 
manipulations (Ishida et al., 1992) and it may function as a cell-death inducer. 
The function of BAG-1 and PD-1 is contradictory but in this experiment, these 
two genes were expressed in PGE2 induced JCS cells. Further experiments thus 
need to be done to check the expression of these genes. 
Transcription factors & DNA-binding proteins 
Homeo box protein 2.4 (HOX-2.4) is also known as HOXB-8. Increasing 
concern is put in its role towards limb development. RA rapidly induces hoxb-8 in 
the absence of protein synthesis and HOXB-8 links retinoid signaling with 
polarizing activity and the establishment of the zone of polarizing activity (ZPA) (Lu 
et al” 1997). By involving in the signaling pathway of RA, HOXB-8 may also 
take part in cell differentiation since RA is a well-established inducing agent 
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(Breitman et al” 1994). 
Neurotransmitter receptors 
Three type of neurotransmitter receptors were upregulated in this experiment, 
they are the 5-hydroxytryptamine (serotonin) receptor le beta, the acetylcholine 
receptor delta subunit and the glutamate receptor; ionotropic AMPA 1. Although 
these receptors are not known for their function in cell differentiation and 
proliferation, it is worth to understand them more. 
5-hydroxytryptamine receptor is a new member of the G protein-coupled 
receptor family that belongs to the 5HT1 group. Its expression is predominantly in 
the hippocampus and when stably expressed in NIH-3T3 cells, the receptor is 
negatively coupled to adenylate cyclase (Amlaiky et al., 1992). 
Acetycholine receptor (AChR) is a pentamer composed of two-ligand binding 
a- subunits and one p., y- and 6- subunit. The AChR is a transmembrane channel 
that opens when it binds nerve-released acetycholine, allowing rapid passage of 
small cations (Sine and Claudio, 1991). 
Glutamic acid is an important excitatory neurotransmitter in the mammalian 
CNS and the synaptic transmission is mediated mostly by the ionotropic glutamate 
receptors AMPA with fast kinetics (Lerma et al., 1997). It has been shown that 
functional ionotropic glutamate receptors is induced with terminal differentiation of 
the embryonic carcinoma cell lines NT2 and PI9 into neuron-like cells by retinoic 
acid treatment (Gonoi et al., 1994). 
Growth factors, cytokines & chemokines 
Macrophage inflammatory protein 1 P (ACT 2) is the cytokine that has been 
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implicated in the regulation of haemopoiesis. Its upregulation is not surprising as it 
is an immediate early response gene and it is rapidly and transiently induced in 
macrophage by lipopolysacharride (LPS), serum or cycloheximide. Its promoter 
site is bound by nuclear protein complexes containing cAMP-independent members 
of the ATF-CREB family and C-JUN (Proffitt et al, 1995). 
4.5.2 Genes with decrease expression 
In this study, a total of 56 genes were shown to be down regulated for more 
than two-fold, in which 26 genes showed more than four-fold decrease. 3 genes 
were with detectable hybridization signals in uninduced cells but none in the PGE2 ‘ 
induced cells, and they were considered to be PGE2 repressed genes. As quite a 
number of genes had been down regulated, those genes that are inter-related will be 
discussed in the following. 
The best known gene being down regulated is the c-myc. This gene encodes 
two closely related nuclear proteins that bind DNA with high affinity. The down 
regulation of c-myc is thought to be a critical determinant in cell differentiation and 
a decrease in c-myc mRNA expression is usually seen when cells are induced to 
differentiate. One example is that when murine C2C12 myoblasts are induced to 
differentiate into multinucleated myotubes, the level of c-myc has decreased for 
three to ten folds (Yeilding et al., 1998). Ras and Raf signal transducers are 
involved in positive regulation of the c-myc promoter and the expression of c-MYC 
protein is found to correlate with the proliferation status of cells and its function has 
been shown to be necessary for cell proliferation (Kerkhoff et al., 1998). 
Cyclin B2 and cyclin E was also downregulated. In general, the B-type 
cyclins appear during the G2/M phase transition of the cell cycle and there are 
lineage- and developmental- specific differences in the pattern of the B cyclins in 
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mammalian germ cells (Chapman and Wolgemuth, 1993). Cyclin E and c-myc 
have shown to promote cell proliferation (Alevizopoulos et al., 1997). During 
oncogenesis, oncogenic activation of c-myc, and possible also of cyclin E, mimics 
loss of the pl6/pRb pathway (Alevizopoulos et al., 1997). Coexpression of RAS 
with MYC allows the generation of cyclin E- dependent kinase activity and the 
induction of S phase (Leone et al., 1997). Although there are no direct evidence 
indicating the relationship between cyclin E and c-myc, they may have a similar role 
in regulating cell differentiation process. 
For prothymosin alpha, it is a gene which transcription is activated by MYC 
(Eilers et al., 1991). Prothymosin alpha is a nuclear protein that may play a role in 
mammalian cell proliferation (Eilers et al” 1991). The exact function of this gene 
is not well elucidated. As its transcritpion links to MYC, the down regulation of 
this gene is reasonable since expression of c-myc was also decreased. 
VAV has a leucine-rich region, a leucine-zipper, a calponin homolgy domain, 
an acidic domain, a Dbl-homology domain, a pleckstrin homology domain, a 
cysteine-rich domain, two Src-homology 3 domains, with a proline-rich region in 
the amino-SH3 domain, and finally an Src homology 2 domain. These domains 
have been implicated in protein-protein interactions and it strongly suggests that vav 
is involved in signaling events (Romero and Fischer, 1996). This gene may 
influence the expression of c-myc as c-MYC is absolutely required for the 
morphological transformation of fibroblasts by either ras or vav, and c-MYC 
functions downstream of signaling pathway induced by either the gene (Katzav et al., 
1995). 
4.5.3 Study of gene expression profile by microarray 
In this experiment, microarray was used to detect the gene expression profile of 
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JCS cells under 5 hours PGE2 induction. As each membrane contains 588 genes, 
the expression profile of the genes can be detected in one experiment. However, 
though mass data can be obtained, this is difficult to interpret the results and the 
relationship among the gene can hardly be found. The first challenge by using 
microarray is to exact the functional information from such large-scale gene 
expression data (Zhang, 1999). Besides, as all the genes dotted on the array are 
known genes, we cannot detect any novel gene expression in such method. 
The arrays were purchased from Clontech，the experimental conditions were 
well controlled and optimal result should be obtained. This helps to save time for 
trial of optimal experimental conditions. On the other hand, the time needed for 
interpreting the result was comparatively long. In this experiment, ^^ P was used in 
the labeling reaction. This isotope provides greater sensitivity in the Altas 
procedure, but it fails to offer the advantage of higher-resolution signals. High 
signal bleed generated had led to a more complicated interpretation of the results. 
Since hundreds of genes were dotted on the membrane, the distance among the 
genes was short and so the signals should be carefully screened. Those highly 
expressed genes may affect the signal of the neighboring gene and the accuracy of 
the results was lowered. 
Moreover, the results were strongly related to the exposure time to the X-ray 
film. Usually, an overnight exposure is not sufficient to reveal hybridization 
signals from rare- to medium-abundance mRNAs, and a 3- to 7-day exposure will 
reveal hybridization signals for only about 20-70 % of the arrayed cDNAs 
(suggested in the Atlas™ cDNA Expression Arrays User Manual). 
The Atlas array was designed to reveal the differences in expression patterns of 
hundreds of gene simultaneously in two different RNA populations. In other 
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words, we cannot detect the expression level of the gene at different time points. 
This may limit our understanding to the overall gene expression pattern. In this 
experiment, we hope to detect those early response genes under PGE2 induction and 
so a 5 hours induction was chosen. The expression profile may be more complete 
if other time points, such as 1，18 and 48 hours induction are also compared. 
Although one can buy more than one sets of array to perform such experiment, it is 
quite expensive. There are also difficulties in stripping off the probe. Even the 
probe is successfully stripped away; the efficiency of reprobing is highly reduced. 
The use of microarray brings lots of information, but before it is widely applied 
to different investigations, the method to detect the signals and the skill to interpret 
the results still need further development. 
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Chapter 5 General discussion 
5.1 Introduction 
Haemopoiesis is the process from which blood cells are formed. Disorder of 
haemopoiesis leads to leukemia. The regulation of the process is highly complex 
and involves lots of regulators, prostaglandins (PGs) is one of them. Among 
different prostaglandins being reported, PGE: is able to regulate haemopoiesis (refer 
to section 1.3.4). In this project, the roles of PGE^ in WEHI-3B JCS myeloid 
leukemia cell differentiation and normal haemopoieis were investigated. 
5.2 Roles of PGE� in JCS cell differentiation 
Among PGD2, PGE2 and PGJ2, PGE2 was showed to inhibit JCS cells growth in 
the highest extent, while PGJ2 was the less potent one to inhibit cell growth. The 
antiproliferative activity of PGE? is also found in other studies. For example, 
certain murine B cell lymphomas are growth-inhibited and ultimately killed by a 
mechanism of apoptosis after PGE? treatment (Brown and Phipps, 1997). Our 
results also showed that PGE2 is the most potent one to induce JCS differentiation 
towards monocytic lineage. When 25 i^M of PGE2 was added to cell culture, more 
than 70 % of cells was drove to differentiate into macrophage while only a small 
portion of PMN was found (Table 2.2). 
Prostaglandins exert their effect through the stimulation of receptors. For 
PGE2, there are four types of receptors (EP receptors) being identified. In this 
project, the expression of EPl, EP4, EP3a, (3 and y in JCS cells is investigated. It 
is found that EPSy is expressed in JCS cells while EPl and EP3a, p are not 
expressed. The expression EP4, however, still needs further investigation. Since 
PGE, favors the monocytic differentiation of JCS cells，and EPSy is found to couple 
to the stimulation and inhibition of adenylate cyclase (Irie et al” 1993), such 
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regulation of adenylate cyclase may take part in the monocytic differentiation of JCS 
cells. 
JCS cells can be induced to differentiate into both granulocytic and monocytic 
lineages. Some genes may be responsible for such lineage preference 
differentiation. PGE2 was thus used to induce JCS cells and it is hoped that the 
gene expression pattern can help us to understand more about the formation of 
monocytes. 
After the induction of 25 i^M PGE2, the gene expression profile was detected 
by microarray. From the result (Table 4.6)，17 genes were upregulated or induced 
by PGE2, in which 4 genes had showed more than four-fold increase. There were 
11 genes with detectable hybridization signals in PGE2 induced cells but none in the 
uninduced cells. They were considered to be PGE: induced genes. On the other 
hand, a total of 59 genes were shown to be down regulated or repressed by PGE2. 
56 genes were downregulated by more than two-fold, in which 26 of them were 
down regulated by more than four-fold. 3 genes were with detectable hybridization 
signals in uninduced cells but none in the PGE2 induced cells, and they were 
considered to be PGE2 repressed genes. 
Most of the regulated genes were oncogenes and tumor suppressors. Those 
regulated genes that were involved in cell differentiation were listed at Table 5.1. 
Actually, the most suitable way to investigate the lineage response genes or the 
differentiation markers is to compare also the gene expression profile of JCS cells 
that will be induced to differentiate towards granulocytic lineage. According to 
personal communication with Dr. N.K.Mak, it will be made possible as a new clone 
of JCS cells was studied which have the above property. 
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Table 5.1 Regulated genes that are related to cell differentiation/proliferation 
Gene Known functions Expression in PGE2 
induced JCS cells 
jun-d -Member of AP-1 proteins which activity is generally Increased expression 
associated with proliferation. Also act as signaling for 2.42 folds 
component in various differentiation processes 
(Rezzonico et al., 1995) 
-JUNd/Fra-2 API complex inhibits the proliferation of 
IL-6 dependent cell lines 
(Rezzonico et al., 1995) 
c-erbA -Encodes thyroid hormone receptor-a which functions to Increased expression 
modulate retinoic acid response and RA-stimulated for 8.36 folds 
neural differentiation 
(Lee et al., 1994) 
Vegfrl -Important in differentiation of the endothelial lineage Increased expression 
and in the neovascularization of developing organs for 11.01 folds 
(Breier et al., 1995) 
b-myb -Abrogrates growth arrest, terminal differentiation of Ml Induced to express 
cells induced by IL-6 
(Bies et al., 1996) 
c-jun -Member of AP-1 proteins. Constitutive expression of Induced to express 
c-jun could induce partial macrophage differentiation in 
U-937 cells (Szabo et al” 1994) 
b-raf -Involved in those regulating proliferation and Induced to express 
differentiation of haemopoietic precursors (Eychene et 
al., 1995) 
Cdk 5 -Highly expressed in neurons that are terminally Induced to express 
differentiated (Ino et al., 1994) 
c-myc -Decrease in expression for 3-10 folds when murine Decreased expression 
C2C12 myoblasts were induced to differentiate into for 25 folds 
multinucleated myotubes (Yeilding et al., 1998) 
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5.3 Roles of PGEj in normal haemopoiesis 
The effect of PGE2 in normal haemopoiesis was tested by colony assay. 
Different concentrations of PGE2 were used to culture with normal bone marrow 
cells. 25 |iM PGE2 drastically increased the granulocyte colonies up to 71 % and 
suppressed the macrophage colony formation down to 4 % (Table 3.3). When 
higher concentration of PGE2 was used in the test, the total number of colonies being 
found decreased (Figure 3.3). It is thus concluded that PGE2 can suppress the 
formation of macrophage colonies in the highest extent among the three types of 
colony being counted. 
Our results also match with other similar studies. PGE2 is reported to regulate 
macrophage production mainly by inhibited macrophage formation at the progenitor 
cell level (Williams and Jackson, 1980). Moreover, in human haemopoiesis, PGE? 
is found to markedly reduced M-CSF synthesis by bone marrow stromal cells (Bess 
et al.’ 1999). 
It has been shown that PGE2 exerted a totally different effect on JCS cells and 
bone marrow cells. It favors monocytic differentiation of JCS cells while suppress 
macrophage colony formation in bone marrow cells. Since the process of cell 
differentiation and haemopoiesis is very complicated, such difference cannot be 
explain in a single way. It was shown that the main difference between the two 
groups was the expression of EP3a and EPS(3 receptors. EPl and EPSy was 
expressed in JCS cells and for bone marrow cells, EPl, EP3a, p and 丫 were 
expressed (Figure 3.6). And again, the expression of EP4 in bone marrow cells 
still needs more investigation. 
The three types of EPS receptors are couple to different G protein and give 
different G protein-linked signaling to the cell. EP3a and P induced enhancement 
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of adenylate cyclase stimulation with different efficiences (Harazono et al” 1994) 
while EP3Y coupled to both stimulation and inhibition of adenylate cyclase (Irie et 
al., 1993). It is not known whether this was a main cause for such difference action, 
but surely it may be one of it. 
5.4 Further studies 
More experiments still need to be done to verify the exact role of PGE? in JCS 
cell differentiation and proliferation. Functional test should be done to confirm the 
maturity of PGE: induced cells. Flow cytometry can also use to give a more 
precise result in telling the number of differentiated cells. Since PGE2 plays a role 
in inhibiting cell proliferation and promoting cell differentiation, in vivo 
tumorigenicity assay can be done. 
The mechanism in how PGE2 gives its effect is still unknown. In this study, 
we hope to find out the type of EP receptors expressed in JCS and bone marrow 
cells. Though we have confirmed that ep3a, p，y are expressed differently among 
the two cell groups, expression of the remaining EP receptors is still unclear. New 
primers can be designed and RT-PCR can be repeated to ease the question. After 
knowing the types of receptors expressed, we need to work out their role in cell 
differentiation and proliferation. By the use of agonists and antagonists, we can 
check the action of different EP receptors and such kinds of chemicals are already 
classified and available in the market. Since the action of some EP receptors is 
related to the stimulation of adenyl cyclase and cAMP, the cAMP elevating and 
inhibiting agents can also be used to evaluate the effects of PG in the JCS cells 
culture. Forskolin and dbcAMP were examined for their action in JCS cell 
proliferation and differentiation. It was found that both of them inhibit the growth 
of JCS cell proliferation and drove the cell to differentiate into monocytic lineage. 
The result is preliminary and still needs conformation. Although it cannot directly 
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explain the action of PGE?，it provides some direction in studying PGE?. 
To understand more about the gene regulation in cell differentiation, we can 
further examine the regulated genes being reported in Chapter Four. Among the 76 
regulated genes, we can concentrate to study some of them. One of the methods is 
to examine their expression at different time point of induction. This can be done 
by RT-PCR or Northern blotting. Another approach is to repeat the whole set of 
microarray experiment. Gene expression profile from different times of induction 
can be compared. Alternatively, gene expression profile can be studied by 
comparing the normal JCS with various leukemia subclones. 
In conclusion, PGE2 may be used, together with other anti-leukemia therapies, 
to inhibit the growth of leukemia cells. The results presented in this thesis may 
help us to understanding the mechanism involved in haemopoiesis. 
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